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Chapter 1
Summary
To become biologically active, most proteins need to fold into precise three dimensional
structures. It has been well established that all the folding information is contained
within the primary structure of a protein. However, the mechanisms utilized by proteins
to avoid sampling the extraordinarily large amount of possible conformations during
their folding process are just beginning to be understood. Molecular chaperones assist
the folding of newly synthesized and denatured proteins in acquiring their native state
in the crowded intracellular environment.
As a nascent chain leaves the ribosome, it is captured first by the upstream chaper-
ones and then possibly transferred to the downstream chaperonins. GroEL-GroES, the
Hsp-60 of E.coli, is one of the best studied chaperone systems. An appreciable amount
of data is available providing information regarding its structure and function. GroEL
encapsulates the substrate into the central cavity where folding occurs unimpaired by
aggregation and unwanted inter-molecular interactions. Nevertheless, many important
aspects of the GroEL mechanism remain to be addressed. Some of the open questions
we have addressed in this study include: In what conformation does a substrate protein
bind to the apical domains of GroEL; how is it that GroEL is able to accelerate the rate
of folding of certain proteins, and how do the conformational properties of the substrate
change as it undergoes repeated cycling.
By using ensemble FRET and Sp-FRET (Single Pair-Fluorescence Resonance Energy
Transfer), we have probed the conformation of the model substrate DM-MBP (Dou-
ble Mutant Maltose Binding Protein) during different stages of the functional cycle of
GroEL. With Sp-FRET coupled to PIE (Pulsed Interleaved Excitation), we have been
able to explore the heterogeneity of the GroEL bound substrate protein and observed a
bimodal conformational distribution. One of the two populations is as compact as the
native state, whereas the other is as extended as the unfolded protein in denaturant.
This unfolding is a local phenomena and can also be observed when the substrate is
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6transferred from DnaK/J system (bacterial Hsp70) to GroEL, indicating the possibility
of the existence of this conformational heterogeneity in vivo as the protein follows the
cellular chaperone pathway.
Subsequent to GroEL binding, there is a transient expansion of the protein upon
binding of ATP to GroEL, followed by compaction when GroES triggers the encapsu-
lation of the protein inside the chaperonin cage. This transient expansion is however
found not to be a necessary event for the rate acceleration of DM-MBP folding, since
ADP-AlFx (transition state analogue of ATP hydrolysis) results in a much slower rate
of expansion, which does not cause a change in the folding rate.
Anisotropy measurements, probing the freedom of motion of different regions of the
GroEL bound protein, revealed that there is a segmental release of the substrate pro-
tein from the GroEL surface upon binding of ATP and GroES. As a consequence, the
hydrophobic collapse of the protein upon encapsulation by GroES follows a step-wise
mechanism. In this process, less hydrophobic regions are released upon binding of ATP,
prior to more hydrophobic ones which are released only by GroES binding. Thus, the
order of Hydrophobic collapse is reversed as compared to spontaneous folding possibly
resulting in conformationally different folding intermediates.
Evidence that the folding pathway inside the cage differs from that of spontaneous
folding was obtained by observing the effect of external perturbations (e.g. mutations in
substrate protein and use of different solvent conditions) on the rate of spontaneous and
GroEL assisted folding reactions. These two folding reactions respond differently to the
introduced perturbations. Kinetic data obtained from ensemble FRET measurements
suggest that the conformation of refolding intermediate is altered by the GroEL cavity,
which leads to a folding pathway that is different from the spontaneous refolding pathway.
In summary, this study revealed significant novel aspects of the GroEL folding mech-
anism and provided insights into the basis of rate acceleration of the substrate protein by
the chaperonin. This work may thus contribute to advance our fundamental knowledge
of the chaperonin system and the basic mechanism of protein folding.
Chapter 2
Introduction
2.1 Protein Folding
Proteins constitute more than half of a cell’s dry weight. Proteins determine the shape
and the structure of a cell and also serve as the main instruments of molecular recogni-
tion and catalysis. In computer terminology, the DNA and mRNA molecules represent
the software instructions that a cell receives from its parent. Proteins and catalytic
RNA molecules are the hardware or machinery that executes the program stored in the
memory.
The process by which a protein acquires its unique three-dimensional structure is
called protein folding. The importance of protein folding has been recognized for many
years. Over half a century ago, Linus Pauling discovered two quite simple regular ar-
rangements of amino acids; the α helix and the β sheet that are found in almost every
protein (Pauling and Corey, 1951a; Pauling and Corey, 1951c). The pioneering discovery
of in vitro protein folding by Anfinsen demonstrated that formation of the native protein
from the unfolded state is a spontaneous process determined by the global free energy
minimum, and is encoded in the primary sequence of the protein.
Proteins are linear polymers of up to 20 different amino acids (aa). All amino acids
contain an amino - and a carboxyl-group covalently linked to a central Cα- atom. In
addition, a functional group (or a hydrogen atom) is coupled to the Cα- atom, which is
different for each amino acid. In a condensation reaction, amino acids can polymerize
to polypeptides (or proteins) via the formation of a planar peptide bond. The peptide
bonds form the backbone of the protein. In all organisms, proteins play a pivotal role in
all cellular processes such as maintenance of cellular structure and integrity, inter- and
intra-cellular communication, metabolism and transport. To fulfill these functions, pro-
teins must adopt specific three-dimensional structures, which are very diverse, including
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fibrillar shapes of structural proteins, globular structures of some metabolic enzymes and
channels traversing membranes in energy producing systems.
2.1.1 Protein Structure
Four hierarchical levels of protein structure are distinguished: The primary structure is
the sequence of the different amino acids and the secondary structure refers to common
repeating structures found in many proteins. The two most common secondary structure
elements are the α-helix and the β-pleated sheet (Pauling and Corey, 1951b). The ter-
tiary structure describes the overall structure of the folded polypeptide chain, including
the arrangements of secondary structural elements. The quaternary structure constitutes
the arrangement of subunits in an assembly of two or more polypeptide chains. Many
proteins are organized in a modular fashion. These modules are referred to as domains,
which are typically 100 to 300 aa in length and are structurally and functionally distinct
units (Doolittle, 1995; Orengo et al., 1994). Linking two or more domains on the pri-
mary structure level has facilitated the evolution of polypeptides with novel functions
(Kummerfeld and Teichmann 2005). Multi-domain proteins occur in all kingdoms of
life, although they are more abundant in eukaryotes than in prokaryotes (65% vs. 40%,
respectively) (Ekman et al., 2005).
2.1.2 Protein Folding: the Determinants of Structure
Pioneering experiments on protein folding were performed in the late 1960’s by Anfinsen
and co-workers. Purified, denatured Ribonuclease A was shown to be able to regain
its native state in solution upon removal of denaturant, as measured by its enzymatic
activity, in a spontaneous and unaided fashion (Anfinsen, 1972; Anfinsen, 1973; Taniuchi
and Anfinsen, 1969). These experiments demonstrated that the information defining the
tertiary structure of a protein is contained within its amino acid sequence. The native
tertiary structure is the polypeptide conformation with the lowest free energy in phys-
iological conditions. The spontaneous folding process was found to be reversible and
occurred on a biologically relevant time scale (Schechter et al., 1970). Usually, folding
does not involve the formation or breakage of covalent bonds. Rather, the polypeptide
is conformationally flexible through rotation around single bonds. The natively folded
structure is stabilized by a multitude of weak interactions, such as hydrogen bonds and
hydrophobic and ionic interactions. Considering only the protein backbone, rotation can
occur around the axis formed by the Cα and the carboxyl carbon as well as around the
axis formed by the Cα and the amino nitrogen, described by the angles ψ and φ, respec-
tively (Fig.2.1). No rotation can occur around the axis formed by the peptide bond due
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Figure 2.1: Steric Limitations of the Peptide Bond Angles in a Protein.. Each amino acid
contributes three bonds to the polypeptide backbone. The peptide bond is planar (blue shading) and
does not allow rotation. The N-Cα and Cα-C bonds, however, allow rotation - their angles are called φ
and ψ. R is used to indicate the side chain residues of the corresponding amino acid.
to its planar nature. Thus, the conformation of the backbone can be described by a pair
of angles, ψ and φ, for each peptide bond. It was found that two of the numerous possible
pairs of ψ and φ occur with a high frequency in natively folded proteins (Ramachandran
et al., 1963). These two pairs of angles are referred to as the α and the β conformation.
2.1.3 Levinthal Paradox and Folding Mechanisms
There are at least 100 fundamentally different folds adopted by natural protein domains
and many variants within these. The question of how individual proteins efficiently
and reliably achieve their native state following synthesis is one of the most intriguing
problems in structural biology. The fundamental question is how a sequence codes for
the fold. Two features of proteins make this question particularly intriguing. Firstly,
since the main chains of all proteins have an identical composition, how do the side
chains dictate the over all fold. Secondly, since the number of possible conformations
of a polypeptide chain is astronomically large, how does a given polypeptide find its
native structure in a finite time? The latter problem is known as the Levinthal paradox
(Levinthal et al., 1962; Plocke et al., 1962).
Levinthal performed mathematical calculations regarding the time that would be re-
quired for a protein to adopt its native structure if the folding process were a completely
random process. If only the two most stable backbone conformations, α and β, are
considered, a hypothetical protein of 150 aa in length can adopt approx.2150 different
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conformations. Taking into account that the fastest possible rate for conformational
changes is approx. 1011s−1, it would take the hypothetical protein more than 1011 years
to reach its native structure (Dinner et al., 2000; Adesnik and Levinthal, 1969). The
discrepancy between the estimated time for random folding and the observed fast folding
of proteins is called the Levinthal paradox.
These considerations led to the conclusion that a protein cannot fold by sampling
the entire available conformational space randomly. Rather, the efficient folding must
proceed through transient intermediates in which local folded elements are stabilized
and determine further folding of the polypeptide (Baldwin, 1996; Baldwin and Rose,
1999; Privalov, 1996). These intermediates would greatly reduce the number of possible
conformations during folding, defining steps of a folding pathway through the random
folding space and thus allow protein folding to take place on a biologically relevant time
scale. Indeed, folding intermediates were observed for various model proteins, such as
Apomyoglobulin, Ribonuclease A, Barstar and Lysozyme (Agashe et al., 1995; Jamin
and Baldwin, 1996; Radford et al., 1992b; Udgaonkar and Baldwin, 1990; Wildegger and
Kiefhaber, 1997).
Three mechanisms were put forth to provide insight into the different modes by which a
protein reaches its native state, namely (Fersht, 1997):
• The framework model proposed that local elements of native local secondary
structure could form independently of tertiary structure. These elements would
diffuse until they collide, come together successfully to give the tertiary structure
(Kim and Baldwin, 1982; Kim and Baldwin, 1990; Ptitsyn and Rashin, 1975).
• The hydrophobic collapse model dictates that a protein rapidly undergoes a
collapse around its hydrophobic side-chains and then rearranges from the restricted
mobility and sterically restricted conformations in which secondary structures are
directed by native like tertiary interactions (Baldwin, 1989; Schellman, 1955).
• The nucleation model states that some residues in a sequence would form na-
tive secondary structure that would act as nucleus from which the native structure
would propagate and the tertiary structure would form as a necessary consequence
of its secondary structure (Scheraga et al., 1984).
The observations made with chymotrypsin inhibitor 2 led to the formulation of a nucle-
ation condensation mechanism, which unifies the different models. It suggests that
both hydrophobic interactions and secondary structural elements stabilize the transition
state (Fersht, 1997). Another example of a two-state folding mechanism is provided by
the bacterial immunity protein Im9 (Ferguson et al., 1999). Interestingly, the analysis of
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the structurally highly homologous proteins Im7 and Im9 revealed that small alterations
in amino acid sequence can lead to a change in the folding mechanism. Whereas Im9
folds mainly via a two state-mechanism, stabilized folding intermediates were observed
for Im7 (Ferguson et al., 1999; Paci et al., 2004). This demonstrated that the folding
kinetics depend on the exact polypeptide sequence rather than on the overall stability
or tertiary structure of the native protein.
Recent experiments involving sophisticated techniques of stopped-flow coupled with
CD and Fluorescence detection, laser induced temperature jump kinetics, Nuclear Mag-
netic Resonance Spectroscopy (NMR) or Mass spectrometry coupled with H-D exchange
paint a more complex picture. In combination with these different approaches, φ-value
analysis (Fersht et al., 1992) and molecular dynamics simulations (Ferguson and Fer-
sht, 2003; Vendruscolo and Dobson, 2005) have provided detailed insights into folding
mechanism in which the behavior of different proteins is quite distinct. This can vary
from being two state folders to those involving well-defined intermediates. However,
most of the analysis is still limited to relatively small proteins of typically less than 100
aa. Detailed kinetic analysis, monitoring the folding of several small proteins by various
techniques, has led to the description of protein folding in terms of an ”energy landscape”
or ”folding funnel” (Zwanzig et al., 1992; Radford et al., 1992a; Dill and Chan, 1997;
Paci et al., 2004)(Fig.2.2).
The energy landscape is a three- or multi-dimensional surface representing the free
energy of a polypeptide molecule as a function of two or more variables, e.g. confor-
mational parameters. An energy funnel is represented by Enthalpy on its Y-axis and
Entropy on its X-axis. Each point on the energy surface represents a conformation of
the polypeptide and the corresponding free energy. The native state of a protein, defined
as the conformation with the lowest free energy, is thus the lowest point in the energy
landscape, or the bottom of the funnel. On the other hand, the denatured protein usu-
ally resembles a random coil in which local interactions dominate the conformational
behavior, which consequently gives rise to a highly heterogeneous state and forms the
top of the funnel. The effect of chaotropic denaturants such as GuHCl or urea is to
solvate the hydrocarbons more readily. Hence, the more solvent exposed the state, the
greater the reduction in its free energy at a given concentration of denaturant. During
folding, the protein follows a route from the top of the funnel, representing a disordered,
denatured state, to the bottom of the funnel. Populated intermediates on the way from
the unfolded to the native protein are local minima in the energy landscape (Radford,
2000; Schultz, 2000; Troullier et al., 2000). If the folding polypeptide cannot escape a
local minimum, it becomes kinetically trapped and eventually misfolds in an off-pathway
reaction. The actual pathway along which a protein folds is dependent on the physical
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Figure 2.2: Schematic Representation of the Free Energy Landscape of a Folding Protein.
The free energy (E) is displayed as a function of two reaction coordinates φ1 and φ2 which describe
the conformation of the folding protein. A multitude of unfolded conformations (U, orange) on the top
enter the funnel that contains an almost indefinite number of local energy minima, representing folding
intermediates (I, green). The folding protein proceeds then through local minima towards the native
conformation (N, blue), which has the lowest free energy. In some local minima, misfolded species may
be trapped irreversibly (M, red).
environment in which the folding reaction takes place.
The solvent environment in vitro and in vivo modulates the stability of local minima
and of inter conversion barriers connecting local minima on the free energy landscape.
Usually, this environmental modulation relative to simple aqueous solvent is small (a
few RT), but the resulting effects can be dramatic. A seemingly small modification of
sequence or environment can cause a protein to unfold or aggregate, fold to a new state,
or accelerate folding dramatically, as seen for the engineered downhill folders. Protein
folding is generally much less favored thermodynamically (protein function often requires
proteins to be flexible and at the brink of stability), yet folding is fast at room tempera-
ture. At its simplest, protein folding can be defined as a directed conformational search
which locates the kinetically accessible state of lowest free energy.
One of the most important sources of energetic frustration in the folding pathway is
enforced by protein function. Proteins evolve for function, not just for thermodynamic
and kinetic foldabilty, and the sequence requirement for function can be incompatible
with efficient folding. Function can affect folding in many ways. For example charged or
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polar residues and water pockets in the protein core may be required for binding of sub-
strates and prosthetic groups, reducing the core’s hydrophobicity, a major driving force
for folding. This suggests that modification of a sequence to more secondary/tertiary-
structure-friendly side chains could speed up folding at the cost of its function. Some
proteins that are constrained by their sequence, topology, size, and function; simply can-
not fold by themselves and are instead prone to misfolding and aggregation.
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2.2 Protein Folding in Vivo
The primacy of the amino acid sequence in determining the final native structure is well
established; however, certain properties of the cellular environment are expected to favor
protein misfolding and aggregation and thereby, drastically reduce the efficiency of the
folding process. High concentrations of solutes and extremes of pH and temperature can
also lead to aggregation and misfolding (Shortle, 1996).
Figure 2.3: Protein Folding in vivo Aggregation of nonnative protein chains as a side-reaction of
productive folding in the crowded environment of the cell. Enhancement of aggregation and chain com-
paction by macromolecular crowding (red arrows). U, unfolded protein chain released from ribosome; I,
partially folded intermediate; N, native, folded protein. Crowding is predicted to enhance the formation
of amyloid fibrils, but this effect has not yet been demonstrated experimentally (from (Hartl, 2002).
There can be numerous reasons for proteins to be misfolded and thus be recruited
into aggregates in vivo (Fig.2.3). Firstly, the folding of the protein in the cell is linked
to its biosynthesis, which is an obligatorily vectorial process (N terminus to C terminus).
As a result, the information for the folding process becomes available sequentially and
not all at once as in the case of in vitro refolding. This incomplete availability of struc-
tural information during translation may not hinder the secondary structure formation
but it greatly limits the formation of native tertiary structure. Secondly, the approx. 30
odd C-terminal residues in the exit tunnel of the ribosome are topologically constrained
and cannot participate in folding reaction until they are released.
In multi-domain proteins, a complete domain can fold in principle as the rate of do-
main folding in vitro is generally much faster (ranging from seconds or less) than the rate
of biosynthesis (4 − 20 amino acids per second). It has also been noted in Eubacteria
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that the rapid rate of translation (approx.5 − 10 times faster than in higher eucary-
otes)(Dobson and Karplus, 1999) would favor a post translational mechanism for folding
at least for those proteins that fold slowly (Netzer and Hartl, 1997). Even a folded do-
main, however, may be unstable because of the absence of interacting domains and these
partially folded unstable structures often expose hydrophobic residues that are otherwise
buried in the native states. This makes these intermediates highly aggregation prone.
The close proximity of such nascent chains due to the translation on polysomes could
also result in intermolecular entanglement. The highly crowded nature of the cellular
milieu (approx. 300 g/l of protein and other macromolecules) presents another obstacle
for efficient protein folding (Zimmerman and Minton, 1993).
Crowding can cause excluded volume effects, which can result in increased inter-
molecular association of unfolded polypeptides (Ellis and Hartl, 1996). This endangers
even those polypeptides, which have escaped misfolding during biosynthesis. The cellular
machinery of chaperones is designed to effectively counteract the tendency of non-native
polypeptide chains to aggregate under the conditions prevailing in the cell. The term
molecular chaperone was originally coined to describe the function of nucleoplasmin, a
nuclear protein that facilitates proper assembly of chromatin by preventing improper
interaction between histones and DNA (Ellis and Hartl, 1996). This specific usage was
later generalized to include a range of functionally related, but diverse, proteins that
assist the folding and assembly of other proteins.
Initially, the emphasis was on mediation of protein assembly but subsequent func-
tional studies with the mitochondrial chaperonin Hsp60 and eubacterial homologue
GroEL, showed the primary role to be in facilitating protein folding (Goloubinoff et al.,
1989). These studies provided the experimental basis for a deviation from the view that
protein folding is generally a spontaneous process, in strong support of the chaperone
concept. Our current definition of a molecular chaperone is that of a protein which tran-
siently binds to and stabilizes an unstable conformer of another protein, and through
regulated binding and release (which may or may not be ATP dependent), facilitates
its correct fate in vivo. Its function can be folding (following de novo synthesis, transit
across a membrane, or stress induced denaturation), oligomeric assembly, interaction
with other cellular components, switching between active and inactive conformations,
intracellular transport, or proteolytic degradation, either singly or with the help of co-
factors (Fink, 1999).
During translation, the majority of polypeptide chains may depend on molecular
chaperones for protection (Hartl, 2002). Once they are released from the ribosome into
the cytosol, chaperones assistance may be restricted to slow folding proteins. Chap-
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erones do not contribute steric information to the folding process, which distinguishes
them from the folding catalysts such as peptidyl-prolyl-isomerases (PPIases) and pro-
tein disulfide isomerases (PDIs). These proteins catalyze specific reactions such as prolyl
isomerisation and disulfide bond formation (Schmid, 1993; Freedman et al., 1994; Puig
et al., 1994).
Figure 2.4: Model for de novo Protein Folding Asisted by a Network of Molecular Chap-
erones in the Cytosol of Bacteria, Archaea and Eukarya. N: Natively folded protein, TF:
trigger factor, NAC: nascent chain-associated complex, PFD: prefoldin. (A) Many proteins in the bac-
terial cytosol fold without further assistance upon release from the ribosome and ribosome-bound TF.
DnaK assists the remainder of proteins in folding, and can transfer substrates to the chaperonin system
(GroEL/GroES). (B) Only some archaea contain DnaK/DnaJ. Interaction of PFD with nascent chains
and existence of NAC is not experimentally confirmed. (C) In the example of the mammalian cytosol,
NAC probably interacts with nascent polypeptide chains together with Hsp70 and Hsp40. The majority
of proteins can fold upon release from these factors. A subset of Hsp70 substrates is transferred to
the Hsp90 system. Furthermore, PFD interacts with nascent chains and transfers these to TRiC, the
eukaryotic chaperonin (Hartl, 2002).
This problem of folding in vivo is so deeply entrenched in living systems that molec-
ular chaperones have evolved and are distributed ubiquitously across all the three king-
doms of life. They act in the cell at all temperatures but the levels of many are greatly
upregulated under stress conditions (Fig.2.4). Therefore, molecular chaperones are also
known as heat shock proteins (Hsps). Their respective molecular weight determines their
names, e.g. Hsp104, Hsp70, Hsp40, Hsp60, Hsp10. More than 20 different families of
chaperone are currently known that have been conserved in evolution. Approximately
one-fourth of these are stress inducible and many of them are essential under normal
conditions of growth. The prominent chaperone families include the Hsp70s, Hsp40s
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(DnaJ), the chaperonins, Hsp90 and the small heat shock proteins. Cells sometimes
need to protect their proteins against many different stress conditions such as the dena-
turing influence of heat etc. with the help of these chaperones or heat shock proteins.
These assist other proteins in not just folding but also in maintaining their folded states.
Some proteins never fold in cells at all except with the assistance of chaperone molecules
that either isolate individual proteins so that their folding is not interrupted by inter-
actions with other proteins or help to unfold misfolded proteins, giving them a second
chance to refold properly.
In general, chaperones do not actively fold their substrate proteins; they rather create
a local environment favoring productive protein folding over functionally non-productive
side reactions. Binding and release of substrate polypeptides by chaperones is often
achieved by ATP-driven conformational changes, allowing multiple rounds of binding
and rebinding between substrate and chaperone machinery, until a native structure is
achieved (Fink, 1999).
2.2.1 Ribosome-Associated Chaperones
Polypeptides are generated and released into the cytosol sequentially from the ribosome
and therefore expose large unstructured and hydrophobic regions during their synthesis.
In order to prevent aggregation of partly completed polypeptides, ribosome associated
chaperones reversibly bind to aggregation-prone nascent polypeptide chains at the ribo-
somal exit tunnel (Hartl, 2002). The first chaperone that interacts with a nascent chain
during their synthesis at the ribosome is trigger factor (TF). It is associated with the
ribosome itself. The 48 kDa E. coli protein binds to a docking site at protein L23 of
the large ribosomal subunit (Kramer et al., 2004a). TF is thought to scan the nascent
polypeptide as it emerges from the ribosomal exit tunnel for hydrophobic regions and
binds to these regions as they are encountered. The TF reaction is not ATPase driven
(Hesterkamp and Bukau, 1996). TF also exhibits peptidyl prolyl cis-trans isomerase
activity, but the biological relevance of this activity for protein folding is still unclear,
since it is not essential for the function of TF in vivo (Genevaux et al., 2004; Kramer
et al., 2004b). It has been shown using fluorescence spectroscopy that TF interacts with
ribosomes and translating polypeptides in a dynamic reaction cycle involving all three
functional domains. Binding to the ribosome conformationally activates TF for nascent-
chain association. Activated TF departs from the ribosome but may remain bound to
the elongating polypeptide thus preventing aggregation and unspecific inter-molecular
interactions (Kaiser et al., 2006).
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2.2.2 Hsp70 Chaperones
The Hsp70 system constitutes a central part of the molecular chaperone arsenal of the
cell. The common mode of DnaK action, the E. coli homologue of Hsp70, appears to be
binding to short, extended hydrophobic peptide sequences in the substrate proteins with
an ATP-regulated and ligand induced change in affinity for binding and release (Liberek
et al., 1991). By shielding exposed hydrophobic surfaces, Hsp70 chaperones prevent
further folding and aggregation of bound substrate proteins for the time they are bound.
Native proteins do not usually expose such hydrophobic fragments and are thus not
recognized by DnaK. DnaK is active as a monomer of 70 kDa and is comprised of two
functional domains: a 45 kDa amino-terminal ATPase domain and a 25 kDa carboxy-
terminal polypeptide binding domain whose structures have both been solved by X-ray
crystallography independently (Harrison et al., 1997; Zhu et al., 1996) but not in an
intact DnaK molecule. Communication between the two domains in the functional cycle
results in efficient binding and release of substrate polypeptides. Recently, structure
of a C-terminal truncated but a functionally intact Hsp70 was resolved that provides
insights into the allosteric mechanisms of the Hsp70 chaperone system. A mutational
analysis of the observed interdomain interface and the immediately adjacent inter-domain
linker identifies inter-domain interactions critical for chaperone function and supports
an allosteric mechanism in which the inter-domain linker invades and disrupts the inter-
domain interface when ATP binds (Jiang et al., 2005).
2.2.3 Hsp60 and Hsp10: The Chaperonins
The chaperonins constitute a conserved class of essential gene products encoded in the
genome of almost every organism sequenced to date, distributed among eukaryotes, ar-
chaea and prokaryotic organisms (Fayet et al., 1989; Knapp et al., 1994; Ostermann
et al., 1989). Chaperonins are large, multimeric, nearly 1 MDa complexes with a double-
ring structure, forming two central cavities. They are divided into two groups, which are
related in topology but do not share close sequence similarity. Group I chaperonins occur
in the bacterial cytosol (GroEL) and in eukaryotic organelles of bacterial endosymbiotic
origin (Cpn60 in chloroplasts, and Hsp60 or Cpn60 in mitochondria). They have a seven-
fold symmetry. Group I chaperonins function in cooperation with cofactors of the Hsp10
family (GroES in bacteria, Hsp10 or Cpn10 in mitochondria and chloroplasts). Group
II chaperonins occur in archaea and the eukaryotic cytosol. The archaeal chaperonin
is called thermosome (Maeder et al., 2005; Hartl, 2002) and the eukaryotic homolog is
called either TRiC (TCP1 Ring Complex) or CCT (Chaperonin Containing T-complex
protein 1) (Stoldt et al., 1996). Group II chaperonins do not interact with Hsp10-like
cofactors, but the function provided by this factor is thought to be directly embedded
into the structure of group II chaperonins themselves (Macario et al., 2004). TRiC has
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an eight-fold symmetry. The detailed introduction to structure and function of chaper-
onins (explained later in the section) is limited to the class I chaperonin homologues of
E. coli, GroEL and GroES.
2.2.4 Additional Chaperone Systems
In addition to the cytosolic chaperone systems described above, a large number of other
cellular factors assist in the folding of newly-synthesized or stress-denatured proteins,
often in co-operation with the Hsp70 system or the chaperonins. Compartments other
than the cytosol, such as the endoplasmic reticulum in eukaryotes or the periplasm in
bacteria, harbor their own unique inventory of specialized molecular chaperones. These
will not be discussed further here.
Small heat-shock proteins, which are often found associated with inclusion bodies
in E. coli, are stress-inducible molecular chaperones that bind unfolded proteins, pre-
venting their aggregation and facilitating their refolding by ATP-dependent chaperones
(Ehrnsperger et al., 1997; Studer et al., 2002; van Montfort et al., 2001). The eubac-
terial proteins IbpA and IbpB are members of this class of proteins. Small heat shock
proteins of the eukaryotic cytosol include Hsp12 and Hsp42 as well as the mammalian
α-crystallins.
The Clp (Hsp100) proteins constitute a subfamily of AAA proteins (ATPases As-
sociated with various cellular Activities). They participate in the re-solubilization of
aggregated proteins in cooperation with the DnaK chaperone system or the protein
degradation machinery (Glover and Lindquist, 1998; Mogk and Bukau, 2004; Schirmer
et al., 1996; Weibezahn et al., 2005). Prefoldin, also called Gim (genes involved in mi-
crotubule biogenesis) complex or GimC (Vainberg et al., 1998), is a hetero-oligomeric
complex of two α and four β subunits that is found in the cytosol of eukaryotes and
archaea. Its structure resembles the shape of a jellyfish with six α-helical coiled-coil
structures protruding from a β-barrel body (Siegert et al., 2000). GimC is able to sta-
bilize non-native proteins, both co- and post-translationally, and transfer them to the
chaperonin (Leroux et al., 1999).
Eukaryotic Hsp90 is a member of the ATP-dependent, homo-dimeric Hsp90 family of
chaperones (Young et al., 2004). Similar to the Hsp70-system, the ATPase activity of
Hsp90 regulates substrate binding and release, but the biochemical mechanism of Hsp90
is not yet fully understood. In contrast to chaperones of the Hsp70 class, it appears to
act at a later stage of the folding process on more compact folding intermediates of a
variety of proteins, including transcription factors, regulatory kinases and other signaling
and structural proteins (Pratt and Toft, 2003; Richter and Buchner, 2001; Young et al.,
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2001). Hsp90 often works together with the cytosolic Hsp70 family member Hsc70, form-
ing the Hsc70. Hsp90 machinery is regulated by diverse co-factor proteins. A feature
often found in these co-factors is a tetratricopeptide repeat (TPR) clamp domain that
mediates interaction with Hsp90, Hsc70, or both. An example of such a co-chaperone is
the mammalian Hsp-organizing protein (HOP), which has two independent TPR clamp
domains and co-ordinates the action of Hsc70 and Hsp90 (Young et al., 2004; Young and
Hartl, 2003). The wide variety of co-factor proteins allows the Hsc70-Hsp90 system to
operate in diverse functional contexts (Young and Hartl, 2003).
2.2.5 Cellular Chaperone Networks
It is highly probable that the multiplicity of intracellular chaperones necessitates a high
degree of functional coordination. One proposed model called the pathway model dic-
tates that the Hsp70 and Hsp40 chaperones- the ”upstream” chaperones (and the trigger
factor in E.coli) bind co-translationally to the majority of newly synthesized proteins and
then relay a subset of those (the slow folders) to the chaperonins or other ”downstream”
chaperone system, which in turn complete the folding process and releases the protein in
the cytosol. The proteins unable to reach the native state may be recaptured by Hsp70s
and targeted for degradation.
Another alternative model is called the network model, which allows all chaperones
to compete for substrate proteins at all times. The non-native states of substrates are
frequently released into the cytosol and captured by any chaperone based on law of mass
action and individual affinities.
Chaperones share the ability to transiently associate with non-native conformers of
proteins by recognizing exposed hydrophobic patches. There are, however, differences
with respect to the molecular mechanism of substrate recognition. E.g. Hsp70, in func-
tional cooperation with DnaJ co-chaperones, binds to short stretches of consecutive
hydrophobic residues in a polypeptide and Hsp60 recognizes hydrophobic patches in sec-
ondary structure elements. The small heat shock proteins (sHsps) form oligomers with
an average size of 12 to 42 subunits. Each oligomer can bind several protein substrates,
up to one molecule per subunit, and thus serves as a very efficient scaffold for misfolded
or unfolded substrates
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2.3 GroE Chaperone System
2.3.1 Structural Information of GroEL-GroES Machinery
GroEL is made up of two oligomeric rings stacked back to back with a cavity at each
end that provides a protective environment for protein folding. Each ring is made of
seven identical subunits of 60kDa. Each subunit consists of three domains: the equato-
rial domain, that contains an ATP binding domain and most of the inter and intra ring
contacts; the apical domain, which forms the opening of the central cavity and contains
the substrate binding site that binds non native polypeptides through hydrophobic in-
teractions and an intermediate hinge-like domain connecting these two domains. The N
terminus begins with the equatorial domain and then continues through the intermediate
domain. The central part of the sequence forms the apical domain and subsequently the
chain returns down through the intermediate domain. Both N and C termini (a total of
30 residues are not resolved in the crystal structure) face the central channel, which is
continuous through the 14-mer in the crystal structure (Fig.2.5).
However, the missing 30 residues per subunit appear to form a central constriction to
Figure 2.5: Asymmetric Structure of the GroEL/GroES Complex. Space-filling models of
GroEL/GroES (PDB 1AON; (Xu et al., 1997) with 6A˚ Van der Waals spheres around Cα atoms.
The two rings of GroEL are red and grey, GroES is shown in blue. Outside view (left) and inside view
(right) of GroEL/GroES, generated by slicing the structure with a vertical plane through the heptameric
symmetry axis. To indicate the interior of the cis cavity, subunits located at the back of GroEL are
colored in green.
the channel as seen in cryo EM images (Chen et al., 1994) (Elad et al., 2007). Mutation of
Lys4Glu (sequence beginning at Met1) completely excludes oligomer assembly (Horovitz
et al., 1993b), suggesting an important structural role for this apparently disordered re-
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gion. The equatorial domain, containing N and C terminal parts of the chain, forms the
backbone of the oligomeric structure. It accounts for most of the inter and intra-subunit
contacts, the interaction between adjacent subunits, and also the only contacts between
the 2 rings in the 14-mer, an important route of allosteric communication (Aharoni and
Horovitz, 1996; Horovitz et al., 1994).
Much of the apical domain surface is not symmetric and closely spaced with neigh-
boring domains. Thus, there is little steric hinderance to its movement, both locally
in some parts and in the overall orientation of the domain. This part of the structure
deviates most from 7-fold symmetry in the crystal.
The helix bundle in the equatorial domain contains the ATP binding site. This pocket
is bordered by a highly conserved sequence motif containing Asp87, GDGTT, and lined
by other stretches of highly conserved residues (Fenton et al., 1994). Mutations in Asp87
excludes the binding of ATP and completely abolishes ATPase activity.
The ATP-binding pocket is adjacent to the lower hinge region and mutations in the
intermediate domain just beyond this hinge region also abolish ATPase activity (residues
150, 151, 152, 405 and 406), as does mutation of residue 383, near the upper hinge re-
gion (Fenton et al., 1994). These strategic locations of key residues around the hinge
regions strongly suggest that hinge movements are involved in the hydrolysis mechanism.
The extensive mutagenesis analysis identified a set of hydrophobic residues on the
apical domain, along the inner channel. This region appears to be flexible in the GroEL
structure. Single amino acid substitutions, at some of these residues (e.g. residues
199, 203, 204, 234, 237, 259, 263, and 264), abolish substrate binding (Fenton et al., 1994).
The ring of 7 binding sites is easily accessible from outside, being very near the surface of
the cylinder, but the inward-facing orientation may protect GroEL from self-aggregation.
Mutation of residue 152, near the lower hinge region, also has a strong effect on substrate
binding (Fenton et al., 1994). The ability of monomeric cpn60, missing 78 N-terminal
residues, to bind substrates and partially promote their folding is consistent with the
apical location of substrate binding sites (Horovitz et al., 1993b; Horovitz et al., 1993a).
GroEL works in conjunction with its co-chaperonin GroES which functions as a lid .
GroES consists of seven identical 10 kDa subunits arranged in the form of a ring (Braig
et al., 1994). Each subunit consists of a barrel region that forms most of the contacts
around the ring and a hairpin pointing slightly upwards and towards the center of the
ring. This region is loosely packed, with little inter-subunit contact, and forms the roof
of the dome-like structure of the oligomer. Earlier NMR work showed that a mobile
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domain in GroES became ordered upon binding to GroEL (Shewmaker et al., 2001).
Upon being capped by GroES, the cavity undergoes an increase in size and the physical
properties of the walls change from hydrophobic to hydrophilic in character. The mobile
region of GroES (residues 17 − 32) not seen on the X-ray structure of GroES, is likely
to form at least part of the binding contact. When in complex with GroEL, the mobile
loop of GroES is probably in contact with GroEL, because its accessibility to trypsin is
reduced in the complex and a synthetic peptide with the loop sequence binds to GroEL
(Landry et al., 1993). Many of the mutations that preclude substrate binding also in-
terfere with GroES binding, suggesting that the binding sites for GroES and substrate
overlap (Fenton et al., 1994). In addition, the GroES binding surface appears to extend
further over the top surface of the apical domain.
2.3.2 Effect of Nucleotides
ATP binding precedes the binding of GroES in the GroEL reaction cycle and results
in a 5-10 degree clock-wise turning motion of the apical GroEL domains (Chen et al.,
1994). ATP binding results in a decrease in the affinity for substrate of GroEL and ATP
hydrolysis drives the key functional cycle of GroEL, regulating between the substrate
acceptor and release states. In the ADP-bound form or without nucleotide, GroEL has
a high affinity for the unfolded substrate, and vice-versa in the ATP-bound form (Stan-
iforth et al., 1994). Alternation between these states has been proposed as the basis of
the assisted folding mechanism. These two states have different conformations in cryo
EM images, with an opening of the apical domains in the presence of ATP. The api-
cal domains open out, elongating the cylinder and widening the binding cavity. ATP
binding makes the hinge regions more flexible. Non-hydrolysable analogues of ATP ap-
pear to cause the same type of cavity opening as ATP but ADP causes a more subtle
change(Langer et al., 1992). ATP is shown to induce asymmetry of the GroEL 14-mer
(Bochkareva et al., 1994).
There is a positive cooperativity exhibited in ATP binding between intra-ring sub-
units and a negative cooperativity between inter-ring subunits of GroEL (Yifrach and
Horovitz, 1996). How these rigid body movements affects conformation of the substrate
bound to the GroEL and how this in turn contribute to accelerated folding of the sub-
strate protein is not well correlated. Although there are a lot of studies exploring the
effect of nucleotide on the conformational changes of GroEL and GroEL substrate inter-
actions, very little is actually available which mechanistically correlates these two aspects
into the folding scheme.
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2.3.3 Substrates of GroEL-GroES
10 - 15 % of all cytosolic proteins in E. coli were observed to transit through GroEL in
vivo (Ewalt et al., 1997; Houry et al., 1999). Despite this relatively low number, which
is based on the nature of the molecular chaperone network inside the cell (described be-
fore), GroEL is able to bind to a large and diverse variety of non-native proteins in vitro
(Viitanen et al., 1992). In a high-throughput approach approximately 250 proteins were
Figure 2.6: Chaperone usage of nascent polypeptides in E. coli upon synthesis on the
ribosome. This model distinguishes three classes of chaperonin dependence. Modified from (Hartl and
Hayer-Hartl, 2002).
identified that were found to functionally interact with GroEL (Kerner et al., 2005).The
selected proteins could be grouped in three classes based on their increasing requirement
for GroEL (Fig.2.6).
• Class I substrates exhibit a low propensity to aggregate upon dilution from denat-
urant and, consequently, only a partial chaperone requirement for refolding in vitro
e.g. Enolase (46 kDa) and glyceraldehyde-3-phosphate dehydrogenase (35 kDa).
• In contrast, Class II proteins do not refold spontaneously under standard conditions
due to their rapid aggregation. They include glutamate decarboxylase α (53 kDa)
and galactitol-1-phosphate 5-dehydrogenase (37 kDa). The presence of both GroEL
and GroES, but not GroEL alone, was shown to be necessary in assisting the
refolding of these proteins at 37◦C. Although GroES was shown to be not absolutely
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required for refolding at 25◦C (Kerner et al., 2005), suggesting that these proteins
are not obligate GroEL/GroES substrates. The DnaK system was as efficient in
mediating refolding at 37◦C. Thus, it is likely that DnaK and GroEL share a
number of substrates mainly in the preferred size range of GroEL (up to 60 kDa),
whereas larger proteins may generally be more adapted for folding by the DnaK
system.
• Class III proteins are found to be stringently chaperonin dependent, e.g. 5, 10-
methylenetetrahydrofolate reductase (MetF-33 kDa), S-adenosyl methionine syn-
thetase (MetK-42 kDa), and DAPA (31 kDa). While METK and METF failed to
refold spontaneously under a variety of conditions known to reduce aggregation,
slow but efficient spontaneous refolding was observed for DAPA in the presence of
0.5 M arginine.
2.3.4 Maltose Binding Protein - Model Substrate
Proteins with an obligate GroEL dependence typically aggregate upon in vitro refold-
ing (Kerner et al., 2005), and thus it is difficult to compare their spontaneous and
chaperonin-assisted folding rates. To avoid this complication, suitability of maltose bind-
ing protein (MBP) as a model substrate was established based on previous reports that
GroEL/GroES can increase the folding speed of a mutant form of MBP (Sparrer and
Buchner, 1997) has been well established (Tang et al., 2006). MBP is a monomeric 41
kDa periplasmic protein that folds robustly in the cytosol when expressed without its
cleavable N-terminal export sequence.
It is composed of two globular domains formed by discontinuous sequence elements con-
sisting of secondary structural βαβ units with the binding site for maltose located in a
cleft between the domains (Fig.2.7)(Spurlino et al., 1991).
Several slow-folding mutants of MBP are known, for instance, the single mutant
Y283D (SM-MBP) and the double mutant V8G/Y283D (DM-MBP) (Wang et al., 1998).
Mutations V8G and Y283D are located in close proximity in a strand and loop segment,
respectively, of the N-domain. Formation of native contacts within the N-domain is hy-
pothesized to be rate-limiting for folding and is further slowed by these mutations (Chun
et al., 1993). MBP possesses eight tryptophans distributed over both domains (Fig.2.7).
Their fluorescence signal is reduced about 5-fold upon unfolding, and the recovery of
fluorescence can be used as a measure of folding (Chun et al., 1993) both in the presence
and absence of GroEL/GroES, which lack tryptophan residues. Importantly, GroEL-
GroES is shown to accelerate the rate of refolding of SM-MBP by about 3-fold and that
of DM-MBP about 13-fold compared to spontaneous folding (Tang et al., 2006; Sparrer
and Buchner, 1997).
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Figure 2.7: Ribbon diagram of the structure of MBP (Spurlino et al., 1991; pdb 1OMP; DS
Viewer- Pro), indicating the positions of mutated amino acids (green). The two discontinuous domains
are shown in blue and yellow, respectively; the eight tryptophans are shown in red. (Tang et al, 2006).
In contrast to GroEL/GroES, the bacterial Hsp70 chaperone system, consisting of
DnaK (Hsp70), DnaJ, GrpE, and ATP, strongly retards the folding of SM-MBP and
DM-MBP. Very similar properties were recently described for several highly aggregation
sensitive, authentic GroEL substrates (Kerner et al., 2005).
Folding rates for this protein and yields are essentially concentration-independent
between 50 nM and 1 µM for wt-MBP (Ganesh et al., 2001) and for the two mutant
proteins (Tang et al., 2006), arguing against reversible aggregation as the cause of slow
spontaneous folding of mutant MBP.
Single event of encapsulation of mutant MBP in the GroEL-GroES cage is sufficient
for accelerated folding, as seen from refolding experiments that are carried out with
the non-cycling single-ring mutant of GroEL (SR-EL), which binds and encapsulates
unfolded protein in a GroES - and ATP-dependent reaction but does not release GroES
(Hayer-Hartl et al., 1996; Weissman et al., 1996). SR-EL/GroES in the presence of ATP
fully reproduces the rate acceleration of SM-MBP and DM-MBP folding observed with
the cycling GroEL/GroES system. Thus, DM-MBP can be considered to be a GroEL
dependent substrate as is also shown in vivo.
2.3.5 Conformational Properties of Chaperonin Bound Sub-
strates
Molecular chaperones are able to discriminate between folded and unfolded proteins.
One of the most obvious features of unfolded proteins is the exposure of hydrophobic
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residues unlike the native or folded state. Very little is known about the substrate bind-
ing specificity of chaperonins. Employing a GroEL molecule comprised of two rings, each
produced as a single continuous polypeptide (Farr et al., 2000), it was possible to deter-
mine more closely the effects of mutations that had previously been observed to abolish
polypeptide binding (Fenton et al., 1994). Three consecutive wild-type apical domains
were found to be necessary to facilitate stable binding of the substrates rhodanese and
malate dehydrogenase in vitro. This arrangement was also found to be necessary to allow
cell viability.
Moreover in another study folding of 30% of cytosolic proteins was found to be af-
fected in a temperature sensitive groEL mutant strain (Horwich et al., 1993). GroEL
does not recognize short peptides or long peptides in extended conformations with high
affinity. Conformational analysis by NMR has shown that a 13mer peptide derived from
rhodanese was weakly bound and stabilized in an α-helical conformation (Landry et al.,
1992; Landry and Gierasch, 1991). Since GroEL also binds β-sheet structures it seems
likely that it binds structural motifs other than secondary structure elements, possibly
the exposure of hydrophobic residues or surfaces.
Negative charges are found to be largely missing from peptides that display high
affinity. Despite the promiscuity in substrate binding there appears to be some under-
lying features pertinent to substrate chaperonin interaction. It has been proposed using
FCS measurements (Pack et al., 2000) the apo-cyt c a positively charged substrate, has
a much stronger affinity for GroEL than do denatured pepsin and reduced Lactalbumin
(rLA), which are negatively charged substrates. Moreover, substrate binding is influ-
enced by cations in the solution and divalent cations are more effective than monovalent
cations depending on substrates.
This enhancement of binding due to positively charged residues could indicate the
importance of ionic interactions at some stage in the binding process, or might simply
reflect the fact that positively charged (as well as hydrophobic) residues can interact with
aromatic side-chains (Burley and Petsko, 1986), such as in the phenylalanine and tyro-
sine residues involved in polypeptide binding on the inner surface of the apical domain
of GroEL (Fenton et al., 1994). Such interactions are known as cation-pi interaction. It
is a non-covalent molecular interaction between the electron-rich pi orbitals of an aro-
matic ring with adjacent cation. Such interactions are relatively strong, being roughly
equivalent in energy to that of a hydrogen bond (Gallivan and Dougherty, 1999).
The main promiscuity of substrate binding by GroEL has been attributed to the plas-
ticity of its hydrophobic binding sites, which results in their association with a multitude
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of substrates (Chen and Sigler, 1999). A high affinity peptide (’strongly binding pep-
tide’, SBP) was identified and crystallized in combination with GroEL apical domains
and the full tetradecameric complex. The binding site for this peptide was found to be a
flexible hydrophobic groove on the apical domains of GroEL, lining the openings of the
cavity. The site was overlapping with the region that accommodates the mobile loop of
GroES when bound to GroEL (Chen and Sigler, 1999). Other peptides which have been
characterized in their binding to GroEL correspond to amphiphilic α-helical regions of
rhodanese (Hlodan et al., 1995).
A number of studies have indirectly attempted to define the conformation of the sub-
strate protein while bound by chaperonin. The binding of substrate protein to GroEL is
usually performed by rapidly diluting the protein from denaturant to the GroEL contain-
ing buffer. Upon dilution into the buffer protein undergo a collapse and form secondary
structure elements on a micro - to millisecond timescale. However, the binding of sub-
strate to GroEL happens on a much slower time scale (seconds), suggesting that the
protein conformation recognized by chaperonin is likely to contain secondary structure.
Substrate proteins for which various conformational parameters have been analyzed
while bound to GroEL include rhodanese (Martin et al., 1991), Dihydro-folate-reductase
(DHFR) (Martin et al., 1991), RuBisCo (van der Vies et al., 1992), β-glucosidase, Pre-
β-lactamase, and α-lactalbumin (Hayer-Hartl et al., 1994). Common features of these
chaperonin bound proteins are high protease sensitivity, tryptophan fluorescence, inter-
mediate to that between the native and the completely unfolded state, partial exposure
of tryptophan residues to the solvent as seen from the emission maxima and significant
adsorption of the hydrophobic fluorescent dye anilino-napthalene sulfonate (ANS).
On the basis of these observations it has been proposed that the conformation of a
chaperonin bound polypeptide resembles that of the so-called molten globule, a compact
folding intermediate that contains secondary structure but lacks stable tertiary inter-
actions. The problem with such optical probes is the uncertainty in interpreting the
signal. The fluorescence of tryptophan may be shifted in wavelength or enhanced by
interaction with the hydrophobic sites on the GroEL, and ANS binding sites may be
formed by pockets in the GroEL: substrate complex rather than those exclusively in the
bound protein. A major goal of physical experiments on chaperonins is to understand
what happens to the conformational properties of folding proteins during their encoun-
ters with the binding surface of GroEL. This information then may lead to the insights
regarding how protein and nucleotide binding energies are used to more efficient folding
of the substrates in terms of rate and yield.
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A crystal structure of GroEL with a complete bound substrate protein bound remains
to be obtained. Problems associated with this are the large conformational variety of
even a single type of bound protein, and the heptameric rotational symmetry of GroEL,
which would decrease the abundance of even a single state of a bound substrate to ap-
prox. 15 % in a crystal. Techniques for following spontaneous folding are relatively bet-
ter worked upon and reasonably well developed such as time resolved CD spectroscopy,
amide hydrogen-duterium exchange coupled to mass spectroscopy and Nuclear Magnetic
Resonance. All of these techniques become impossible or extremely difficult when chap-
eronins are introduced into the equation.
2.3.6 GroEL-GroES Reaction Cycle in Protein Folding
GroEL facilitates protein folding by undergoing rigid body movements that are coordi-
nated in space and time by complex allosteric regulations by ATP binding and hydrolysis.
This serves as a signal for substrate and GroES binding and subsequent release of the
substrate into solution, as well as a clock for the time of encapsulation of the substrate
inside the cavity.
Three affinity states of GroEL for substrate binding can be distinguished: the nu-
Figure 2.8: Reaction Cycle of GroEL-GroES Simplified reaction of protein folding in the GroEL-
GroES cage. I, folding intermediate bound by the apical domains of GroEL; N, native protein folded
inside the cage. For a typical GroEL substrate, multiple rounds of chaperonin action are required for
folding; both I and N accumulate after a single reaction cycle and exit the cage upon GroES dissociation.
I is then rapidly re-bound by GroEL.
cleotide free form, which appears to have the highest affinity for the unfolded protein;
ATP bound form, having lowest affinity for the unfolded protein and the ADP bound
form, which associates with the substrate protein with an affinity closer to that of the
nucleotide free state than the ATP bound state. These forms probably represent dif-
ferent conformational states of GroEL that are inter-convertible by nucleotide exchange
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and ATP hydrolysis (Fig.2.8). The following sequence of steps can be proposed for the
GroEL-GroES reaction cycle:
1. Under physiological conditions, GroEL is in the bullet form the physiological ac-
ceptor state of the GroEL for the protein (Rye et al., 1999). The ”GroEL bullet”
is ADP bound GroEL which is in a complex with GroES and the trans ring in the
substrate acceptor state.
2. Unfolded protein binds to the trans ring of GroEL and triggers ADP dissociation
in the cis ring, which in turn results in the release of GroES.
3. The removal of ADP allows binding of ATP which was regulated by the negative
co-operativity between the two rings. ATP binding reduces substrate affinity for
the bound substrate protein.
4. ATP binding triggers conformational chnages which enables GroES binding to
GroEL in the ATP state and may cover the ring that contains the bound substrate.
Cooperative ATP hydrolysis releases the substrate protein for folding in the ring
cavity.
5. GroES binding becomes stabilized in the regained ADP state and partially folded
protein may re associate for another round of interaction.
The underlying principle of GroEL mediated protein-folding hinges on alternating
cycles of binding and release or substrate protein and GroES until the protein has reached
native state and has buried its hydrophobic patches and thus lost its affinity for GroEL.
Association of GroES with only one of the GroEL rings imparts the asymmetry required
for this process and ensures cooperative inter-ring ATP hydrolysis.
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2.4 Fluorescence
Fluorescence generally is much more sensitive to the environment of the chromophore
than absorption or CD spectroscopy. During the approximate lifetime (10−9 sec) of the
fluorophore all kinds of processes such as protonation or deprotonaiton, solvent cage
relaxation, local conformational changes and any process coupled to translational or ro-
tational motion of the molecule may occur (Steinberg, 1971). Therefore, fluorescence is
used to monitor conformational changes with in a molecule. Fluorescence lifetime and
quantum yield are the most important characteristics of a fluorophore.
The quantum yield is the fraction of excited singlets that decay by fluorescence or
the number of emitted photons relative to the number of absorbed photons. Although
the quantum yield can be close to unity if the radiation less decay rate is much smaller
than the rate of radiative decay; the energy yield of fluorescence is always less than unity
because of stokes’ losses (Fig.2.9).
Singlet
Figure 2.9: Jablonski Diagram It shows a number of possible routes by which an excited molecule
can return to its ground state. A rapid return (in ns) results in fluorescence and a delayed return (in
µs) results in phosphorescence where relaxation happens via the triplet state.
The lifetime of the excited state is defined by the average time the molecule spends
in the excited state prior to return to the ground state. Certain other factors also
affect the intensity of fluorescence (although these need not necessarily directly related
to intensity)such as:
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1. Internal conversion: the process in which excitation energy is lost by collision with
solvent or by dissipation through internal vibrational modes. In general, the process
increases with increase in temperature. This should be particularly noted when
using this method to monitor thermally induced macromolecular conformational
changes.
2. Deexcitation: resulting from collisions or interactions with solute molecules capable
of quenching the excited state.
3. Intersystem crossing: the process in which the nominally forbidden spin exchange
converts an excited singlet into an excited triplet state, which in turn converts to
the ground state either by phosphorescence (emission of a photon) or by internal
conversion. The triplet state is generally lower in energy than the excited singlet.
Hence phosphorescence occurs at longer wavelengths and can be easily resolved
from fluorescence.
A number of fluorescent molecules have a property of being strongly quenched in
aqueous environment but are strongly enhanced (over 20 fold) in a non-polar or a rigid
environment. Fluorescence lifetime determines the time available for the fluorophore in
its excited state to interact with other molecules or diffuse in its environment.
2.4.1 FRET
Analysis of structure, dynamics, and interactions of biomolecules is fundamental for
understanding molecular mechanisms. Fluorescence resonance energy transfer(FRET)
is a powerful method that can perform such an analysis.
FRET is a radiationless transfer of excitation energy from a donor to an acceptor
governed by a long-range dipole-dipole interaction. This mechanism was first elucidated
by Theodore Fo¨rster (Stryer, 1978). FRET is a process which does not involve emission
and re-absorption of photons. The theory of energy transfer is based on the concept of a
fluorophore as an oscillating dipole, which can exchange energy with another dipole with
a similar frequency (Fig.2.11). Consequently FRET contains molecular information inde-
pendent of solvent relaxation effects, excited state interactions, fluorescence quenching,
or anisotropy, except for their effect on the spectral properties of the donor or acceptor.
FRET offers an experimental approach for determination of molecular distances in the
range of 10 to 80 Angstroms through measurement of efficiency of transfer between a
donor and an acceptor located at two specific sites. FRET is also a sensitive technique for
detection of global structural alterations. The donor molecule typically emit at shorter
wavelengths, which overlap with the absorption spectrum of the acceptor. The rate of
the energy transfer depends on the following parameters:
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Figure 2.10: Pictorial representation of the basic concept of FRETA) The prerequisite spectral
overlap between the donor and acceptor molecules. B) The radiation-less transfer from donor to acceptor
upon selective excitation. C) The usage of this technique as a molecular ruler to investigate molecular
dynamics.
1. The extent of spectral overlap of the emissions spectrum of the donor with the
absorption spectrum of the acceptor. The overlap integralJ (λ)expresses the degree
of spectral overlap between a chosen donor and acceptor pair.
J(λ) =
∫ ∞
0
FD(λ)A(λ)λ
4dλ =
∫∞
0 FD(λ)A(λ)λ
4dλ∫∞
0 FD(λ)dλ
(FD) is the fluorescence of donor, A is extinction coefficient of the acceptor ex-
pressed in the units ofM−1cm−1, λ is the wavelength in centimeters. Therefore,the
overlap integral calculated is in units of M−1cm3.
2. The quantum yield of the donor. This parameter has already been discussed
before in the chapter dealing with fluorescence in general. It can be calculated for
a dye of interest under a particular experimental condition by comparing it to a
known standard sample eg. Fluorescein or Quinine Hemi-sulfate.
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Q =
Ft
Fs
× As
At
F is the fluorescence of the test (t) or the standard (s) and A is the absorbance of
the same test (t) or standard (s) at the excitation wavelength.
3. The relative orientation of the donor and acceptor transition dipoles; and the
distance between the donor and acceptor.
The rate of transfer of energy is given by the expression:
KT =
(
1
τd
)(
R0
R
)6
Where RO is the Fo¨rster Radius at which 50% of the excitation energy is transferred to
the acceptor (50% transfer efficiency). If the wavelength is in centimeters and J (λ) is in
the units of M−1cm3, then Forster radius is given by:
R0 = 9.78× 103 6
√
κ2η−4QDJ(λ)
The efficiency of energy transfer (E ) is the fraction of photons absorbed by the donor that
are transferred to the acceptor. This is typically measured using the relative fluorescence
intensity of the donor, in the absence (FD) and presence (FDA) of acceptor.
E = 1− FDA
FD
The transfer efficiency can also be calculated from the lifetimes under these respective
conditions (τD andτDA ):
E = 1− τDA
τD
This expression allows the Fo¨rster Distance to be calculated from the spectral properties
of the donor and the acceptor and the donor quantum yield.
E =
R60
R60 + r
6
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This expression shows that the transfer efficiency is strongly dependent on distance when
the D–A distance is near R0.
Alternatively, energy transfer can be measured between identical chromophores that have
a limited stokes shift and is referred to as homotransfer (Kalinin and Johansson, 2004).
The theoretical analysis of homotransfer is intrinsically complex since it can only be
detected by depolarization experiments and is observed as a decrease in the anisotropy
of a fluorophore at higher concentration.
A major uncertainty in the determination of molecular distances by FRET is in the ori-
entation factor for dipole-dipole coupling. This parameter cannot be determined by any
current solution technique, therefore the distances calculated from energy transfer data
usually are not unique except for cases where an appropriate average value of orientation
factor can be applied.
Early studies were based on the assumption that both donor and acceptor dipoles
randomize rapidly (dynamic averaging) and sample all orientations (isotropic condition)
during the short interval when energy transfer occurs. Under these conditions, κ2 = 2
3
.
Frequently the fluorophore can be limited by the surrounding macromolecular structure.
A variation of κ2 from 4 to 2
3
results in 35% error in the distance calculated but a
variation from 2
3
to 0.01 results in a twofold decrease in R (Dale et al., 1979). There
can be many ways to minimize the uncertainty in orientation factor for using FRET for
relevant estimations of molecular distances rather than just qualitative data namely:
1. Using polarized emission data to define the mobility of donor and acceptor bound
to a macromolecular substrate and to estimate a range of the orientation factor.
2. Choosing donor and acceptor fluorophores that have mixed polarizations and ex-
hibit small limiting polarization properties, and statistical interpretations of energy
transfer data to define the limits for the donor acceptor distance and the most
probable distance.
Resonance transfer energy is also used to study macromolecular systems in which a
single D-A distance is not present such as unfolded proteins or membranes or protein
while they are folding, where there is a distribution of such distances. Such systems are
better studied with time resolved measurements(Bagshaw and Cherny, 2006).
Presence of a distribution has profound impact on the time resolved decays of the
donor. For the native protein, the single D-A distance results in a single transfer rate
for all donors. Hence, the decay time of the donor is shortened, and there is only one
transfer rate as a result of which the donor decay remains a single exponential. It is this
assumption of a single distance which allows calculation of the distance in a steady state
scenario. A range of D-A distances result in a frequency response which is spread out
along the frequency axis, and one which is no longer a single exponential. The goal of
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most distance distribution studies is to recover the D-A probability distribution from the
non-exponential decays of the donor. The information content of such data are limited.
2.4.2 Single Molecule FRET
Protein folding is a process characterized by a large degree of conformational hetero-
geneity. In such cases, classical experimental methods yield only mean values, aver-
aged over large ensembles of molecules. The microscopic distributions of conformations,
trajectories, or sequences of events often remain unknown, and with them the under-
lying molecular mechanisms. Signal averaging can be avoided by observing individual
molecules. A particularly versatile method is highly sensitive fluorescence detection. In
combination with Fo¨rster resonance energy transfer, distances and conformational dy-
namics can be investigated in single molecules. Fluorescence has become a powerful tool
for investigating the dynamics of biological systems and bio-molecules. The availabil-
ity of high sensitivity photo-detectors and small probe volumes obtainable with visible
light have contributed to the development of ultra-sensitive fluorescence spectroscopy
and microscopy methods. Ultra-sensitive fluorescence methods allow one to investigate
the interactions and dynamics of bio-molecules with high accuracy even on the level of
single fluorophores. Such ultra-sensitive methods include fluorescence correlation spec-
troscopy (FCS) and fluorescence cross-correlation spectroscopy (FCCS), burst analysis,
single-molecule studies, single-pair fluorescence resonance energy transfer (spFRET) ex-
periments, and single virus tracing.
In ultra-sensitive fluorescence measurements, it is important to maximize the infor-
mation retrievable with each photon. The more information that is recorded during a
measurement, the more potential exists in the analysis. In fluorescence spectroscopy, the
information available from the photon is the number of photons (intensity information),
the position in space where the photon was detected (image information), the energy of
the photon (spectral information), its polarization (orientational information), and the
delay between excitation and fluorescence emission (lifetime information).
Different methods have been developed that utilize various combinations of the avail-
able information. Additional information is available when multiple excitation sources
are used. Alternating laser excitation (ALEX) was introduced by Kapanidis and col-
leagues (Lee et al., 2005). Two excitation sources were interleaved on a timescale be-
tween 25 and 3000µs, switching between both excitation sources on a timescale faster
than diffusion of the particle through the probe volume.
With pulsed interleaved excitation (PIE), the alternation timescale is pushed to the
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nanosecond regime. For the experimental conditions used for this study, many excita-
tion pulses from all excitation sources illuminate the sample between the detection of
each photon. Hence, on the microsecond timescale, the measurements with the various
excitation sources can be considered to be simultaneous. The faster timescale of the
interleaved excitation allows FCS experiments to be performed with sub-microsecond
resolution in addition to all the other possibilities of ALEX. PIE-FCCS increases the
sensitivity of FCCS by removing any residual cross talk from the cross-correlation func-
tion (CCF). As in ALEX, PIE can also be used to determine the labelling stoichiometry
in spFRET and perform more accurate FRET measurements by including only samples
containing an active donor and acceptor in the analysis.
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Figure 2.11: Single Molecule Instrumentation and Setup. Schematic and photographic rep-
resentation of the dual-color confocal microscope with pulsed interleaved excitation sources. In the
diagram, AOM refers to the acousto-optic modulator, DM to the dichroic mirrors, EM to the emission
filters, PH to the pinholes, L to the lenses, and APD to the avalanche photodiodes.The signal read out is
the excitation pulse train as measured by a photodiode.The green and red excitation pulses are colored
accordingly (Muller et al., 2005).
PIE is the use of two or more pulsed excitation sources, alternated with sufficient
delay that all the emitted photons from one laser pulse are detected before the next pulse
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of a different color arrives. In the system developed by Muller et al, The experimental
setup is based on a two-channel confocal microscope. Two excitation sources were used:
a pulsed laser diode at 635 nm and a continuous-wave, frequency-doubled laser 532 nm,
which was pulsed by an acousto-optic modulator. The lasers were synchronized by a
master clock and one source was delayed by 100 ns with respect to the other. The rep-
etition rate used for the measurements discussed was 5 MHz. The photons are detected
using time-correlated single-photon counting (TCSPC). The data acquisition card and
excitation sources are synchronized with the master clock such that the excitation source
responsible for generating the detected photon is encoded into the arrival time of the
photon. The use of two, subnanosecond pulsed lasers would allow additional capabilities
of PIE by including lifetime information of the fluorophores. From the arrival time,
the excitation source for each photon is known and this additional information can be
utilized in the data analysis.
The data analysis was performed with the in-house software routines written in
PVWave (Visual Numerics, Houston, TX) by Mueller et al. The difference between
ALEX and PIE is that the alternation between green and red excitation occurs faster
than the rate of photon detection. In this work, the repetition rate of the excitation
was 5 MHz, much higher than the typical count rates of 100 kHz. Hence, the relevant
fluorescence information is collected simultaneously. The fast switching rate gives us
the ability to perform auto- and cross-correlation analysis on the collected data with
submicrosecond time resolution. Even for the spFRET measurements, the measured
fluorescence is averaged over the same period in time, and is not affected by significant
diffusion of the particle between alternating excitation pulses.
For spFRET measurements, the intensities of the donor and acceptor fluorescence
are used to determine FRET efficiencies which are empirically determined using the fol-
lowing expression.
fE =
FAD
αFDA + FAD
where α is the detection-correction factor between the green and red channels, FDA
is the fluorescent intensity of the donor in the presence of the acceptor, FAD is the
fluorescent intensity of the acceptor in the presence of donor.
2.4.3 Anisotropy
Anisotropy (the opposite of isotropy) is the property of being directionally dependent.
Something which is anisotropic may appear different or have different characteristics in
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different directions. Fluorescence anisotropy decay belongs to the general class of relax-
ation methods which monitor the time dependence of the transition of the system from
a biased to a random arrangement.
Figure 2.12: The Basic Principle of Anisotropy. The Intensity of fluorescence is monitored first
parallel (VV), then perpendicular (VH) to the excitation which is then used to calculate anisotropy
which reports the conformational mobility of the probe under study.
The origin of this phenomenon is based on the existence of transition moments for
absorption and emission, which lie along specific directions within the fluorophore. In
homogenous solutions ground state fluorophores are randomly oriented. Upon excitation
with polarized light only those fluorophores get preferentially excited whose absorption
transition moment lie along the electric vector of the incident light. Anisotropy (r) can
be measured by the following expression.
r =
I‖ − I⊥
I‖ + 2I⊥
Where I‖ and I⊥ are parallel and perpendicular components of the monitored flu-
orescence. By measuring the intensity of emitted light polarized perpendicular to the
stimulating radiation, and comparing it with the intensity of light emitted parallel to
the stimulating radiation over time, we obtain a measure of how easily the molecules
change their orientation. The measure is an anisotropy decay curve, which tells us what
proportion of the emitted light is polarized in the same sense as the stimulating light
at various times after stimulation. The goal of the intensity measurements is usually to
measure a signal proportional to the total intensity (It), not one proportional to I⊥ or
I ‖ or else incorrect decay times are recovered. With the use of polarizers, the measured
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intensity can be made proportional to the total intensity, irrespective of the degree of
polarization of the sample, by orienting the excitation polarizer in the vertical position
and and the emission polarizer 54.7o from the vertical. In previous publications one
frequently encounters the term polarization which is given by:
P =
I‖ − I⊥
I‖ + I⊥
Anisotropy has a substantial advantage in many applications because firstly, it is
independent of the total intensity of the sample. Secondly, in multicomponent mixtures
of substances with equal fluorescense intensity but variable anisotropy (Ai) the total
anisotropy(At) is equal to
At =
∑
i χiAi
where(χi) is the mole fraction of the ith component. However, polarization and
anisotropy can be inter converted by the relationship.
P =
3r
2 + r
r =
2P
3 − P
The anisotropy measurement reveals the average angular displacement of the fluorophore
that occurs between absorption and subsequent emission of the photon. This angular dis-
placement is dependent on the rate and extent of rotational diffusion of the fluorophore
during the lifetime of the excited state. These motions in turn depend on the viscosity
of the medium, size and shape of the particle. Therefore anisotropy measurements have
been used to quantify protein denaturation, its association with other macromolecules
or in this case the internal dynamics of the protein.
Steady state anisotropies are measured using continuous illumination and represent
an average of the anisotropy decay over intensity decay. Measurement of steady state
anisotropy decay is simple, but its interpretation usually depends on an assumed form
for the anisotropy decay, which is not directly observed in the experiment. Additional
information is available if one measures the time-dependent anisotropy, that is, the values
of r(t) following pulsed excitation. The form of the anisotropy decay depends on the size,
shape, and flexibility of the labelled molecule. It is valuable to understand the factors
that can affect anisotropy decays.
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Shape: For a spherical molecule, the anisotropy is expected to decay with a single
rotational correlation time (θ). The most common interpretation of the correlation
time is in terms of overall rotational correlation time of the protein. But the
measured values of θ can also result in multi-exponential anisotropy decay curves.
These can be due to non-spherical fluorophores or proteins. In such cases the
correlation times are determined by the rates of rotation of the molecule about
various molecular axes. Thus, anisotropy can also be used to estimate the shapes
of the molecules.
Segmental Flexibility: In addition to shape, anisotropy decay is also affected by the
segmental flexibility of the molecule. For instance, tryptophan anisotropy decays
for proteins frequently display correlation times that are too short to be due to
rotational diffusion of the protein. These short correlation time components are
often due to independent motion of the tryptophan residue within the protein. Such
measurements are widely used to understand the internal dynamics of proteins.
HomoFRET: Anisotropy decays can also be affected by resonance energy transfer be-
tween molecules of the same type of fluorophore, that is, depolarisation due to
homotransfer.
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2.5 Aim of the Study
The GroE chaperonin system is structurally and mechanistically one of the most ex-
tensively studied molecular machines. But despite the large body of data available, the
conformational properties of the substrate protein as it transits the GroEL/GroES cycle,
have remained largely unclear.
Using single molecule and ensemble FRET methods, the aim of this study was to
address the following questions concerning the conformation of a model protein (DM-
MBP) during its Chaperonin (GroEL/GroES) assisted folding.
1. Bound State What is the conformation of the protein when it is bound to GroEL
in comparison to the unfolded state in free solution? Is there heterogeneity in the
bound state or does the bound protein populate a defined conformation? What is
the degree of expansion if observed of the bound protein and how is the nature of
the bound state different between the GroEL and SR-EL chaperonins?
2. Expansion or Compaction As the protein transits the GroEL/GroES cycle, how
does the conformation of the bound protein protein changes as a result of various
events like nucleotide or GroES binding to GroEL?
3. GroEL cycling and the Bound State Does the protein revert to its initial confor-
mation during chaperonin cycling?
4. Segmental mobility Is there a pattern of release for the substrate protein from the
GroEL surface upon binding of nucleotide and or GroES? Does it have a correlation
with the secondary structure elements or hydrophobicity of the different regions of
the protein?
5. Spontaneous and GroEL assisted folding pathway : how does GroEL accelerate the
rate of folding of certain proteins? Does it interact preferentially with the native
state or the transition state of the substrate with out changing the pathway of
folding or does it re-route the pathway resulting in intermediates that are different
from those of the spontaneous refolding pathway.
Chapter 3
Materials and Methods
3.1 Materials
3.1.1 Chemicals
L-Amino acids Sigma-Aldrich
Acetic acid Merck
Adenosine 5’ - (β,γ-imido)triphosphate tetralithium salt
(AMP-PNP)
Sigma-Aldrich
Adenosine triphosphate, disodium salt (ATP) Sigma-Aldrich
Agarose (SeaKem LE) Cambrex Bio Science
Alexa Fluor 488 C5 maleimide Molecular Probes
Alexa Fluor 594 C5 maleimide Molecular Probes
Ammonium persulfate (APS) Sigma-Aldrich
Ampicillin Merck
Amylose resin New England Biolabs
Atto 532 C5 maleimide Atto-Tec
Atto 647-N C5 maleimide Atto-Tec
Bacto agar Difco
Bacto trypton Difco
Bacto yeast extract Difco
Bovine Serum Albumin (BSA) Sigma-Aldrich
Bromophenol blue Sigma-Aldrich
Calcium chloride Merck
CDTA (trans-1,2-diaminocyylohexane - N, N, N’, N’-
tetracetic acid)
Sigma-Aldrich
Chloramphenicol Sigma-Aldrich
Complete EDTA-free protease inhibitor Roche
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Coomassie brilliant blue R-250 Roth
Dimethylsulfoxide (DMSO) Merck
Dithiothreitol (DTT) Roche
ECLTM detection kit Amersham Pharmacia Biotech
Ethanol Merck
Ethidium bromide BioRad
Ethylenediaminetetraaceticacid-sodium
salt(EDTA)
Merck
Glucose Sigma-Aldrich
Glycerol Merck
Glycine Roth
Guanidium hydrochloride (GuHCl) Sigma-Aldrich
HEPES Sigma-Aldrich
Hydrochloric acid (37%) Merck
Isopropyl-β-D-thiogalactopyranoside (IPTG) BioMol
Magnesium chloride Merck
Maltose Sigma-Aldrich
β-mercaptoethanol Sigma-Aldrich
Methanol Merck
Phenyl-methyl-sulfonyl-fluoride (PMSF) Sigma-Aldrich
Polyacrylamide/bisacrylamide solution 30 % (30 :
0.8)
Roth
Potassium hydroxide Sigma-Aldrich
Sodium chloride Merck
Sodium dodecylsulfate (SDS) Sigma-Aldrich
Sodium hydroxide Sigma-Aldrich
Sodium thiosulfate Merck
N,N,N’,N’-Tetramethylethylendiamine (TEMED) Sigma-Aldrich
Tris(2-carboxyethyl)phosphine
hydrochloride(TCEP-HCl)
PIERCE
Tris-base Sigma-Aldrich
Triton X-100 Sigma-Aldrich
Tween-20 Calbiochem
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3.1.2 Enzymes
Apyrase Sigma-Aldrich
Benzonase Merck
Lysozyme Sigma-Aldrich
Pfu DNA polymerase Promega
Restriction enzymes New England Biolabs
Shrimp Alkaline Phosphatase Roche
T4 DNA ligase New England Biolabs
3.1.3 Materials
Centricon 10 kDa cut-off Amicon
Microcon 10 kDa cut-off Amicon
Microcon 100 kDa cut-off Amicon
Nitrocellulose transfer membrane Whatman Schleicher and Schuell
Sterile filter 0.22 µm Millipore
Sterile filter 0.45 µm Millipore
3.1.4 Instruments
AIDA gel imaging software version 2.31 Raytest
AKTA Explorer 100 Amersham Pharmacia Biotech
Balance AG285, PB602 Mettler Toledo
Centrifuges: Avanti J-25, Avanti J20 XP, J-6B, GS-6R Beckmann
Centrifuges 5415C and 5417R Eppendorf
Chromatography columns (HiPrep Desalting, MonoQ,
HiTrap Heparin, Sephacryl S200/S300, Superdex 200,
Superose 6, Sephadex G25 (NAP-5, NAP-10, NAP-25);
chromatography resins: Q-Sepharose, DE52, Source 30
Q, Source 30 S)
Amersham Pharmacia Biotech
Deionization system MilliQ plus PF Millipore
Electrophoresis chambers MiniProtean 3 Bio-Rad
Electrophoresis power supply Power PAC 300 Bio-Rad
Fluorescence spectrometer Fluorolog 3 HORIBA Jobin Yvon
FPLC systems Amersham Pharmacia Biotech
EmulsiFlex high pressure homogenizer Avestin
Gilson Pipetman (2, 10, 20, 100, 200, 1000 µl) Abimed
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Incubators Innova 4430 New Brunswick Scientific
Luminescent Image Analyzer LAS-3000 FUJIFILM
Mini Trans-Blot Electrophoretic Transfer Cell Bio-Rad
PCR-Thermocycler T3 Biometra
pH meter Accumet Basic Fisher Scientific
SMART system Amersham Pharmacia Biotech
Sonicator Ultrasonic Processor XL Misonix Inc.
Spectrophotometer DU 640 UV/VIS Beckmann
Sx.18MV Stopped-Flow Reaction analyser Photo Physics
Synergy HT UV/VIS/fluorescence/luminescence plate
reader
Bio-Tek
UV/VIS Spectrometer V-560 Jasco
Thermomixer Comfort Eppendorf
Vortex Ikamag
Water bath Bioblock Scientific
3.1.5 Media
• LB medium 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl, ( and 15 g/l agar
for solid medium). Adjusted to pH 7.0with NaOH (Sambrook et al., 1989).
• SOC medium 20 g/l tryptone, 5 g/l yeast extract, 0.5 g/l NaCl, 0.186 g/l KCl,
0.95 g/l MgCl2. After autoclave, add 20 ml of filter sterilized 1M glucose (Sam-
brook et al., 1989).
3.1.6 Antibiotic Stock Solutions
Antibiotic additives to growth media were prepared as 1000X stock solutions and filter-
sterilized before usage:
Ampicilin: 100 g/l
Chloramphenicol: 25 g/l
3.2 Plasmids
GroEL and all chaperonin size and charge mutants were constructed in a pCH vector
backbone by Yun Chi Tang (Tang et al., 2006) and were kindly given for use in this
study.All the MBP mutants(cys-derivatives) were generated by site-directed mutagene-
sis in pCH vector on the background of the DM-MBP. Poly-Proline and DM-MBP fusion
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construct was made by introducing synthetic oligonucleotides into the pCH DM-MBP
stop to Gly conversion mutation. GroES was constructed in a pET11a vector inserted
via the NdeI and BamHI sites (Brinker et al., 2001).
The sequences of all final constructs were confirmed by DNA sequencing (Sequiserve
and Medigenomix GmbH). All new DNA constructs used in this work are listed in the
tabulated form.
Plasmid Promoter/Origin Selection marker
PCH-MBP-DM N TERMINAL CYS T7/ColEI Ampicillin
PCH-MBP-DM A52C T7/ColEI Ampicillin
PCH-MBP-DM C TERMINAL CYS T7/ColEI Ampicillin
PCH-MBP-DM A52C/N TERMINAL CYS T7/ColEI Ampicillin
PCH-MBP-DM A52C/C TERMINAL CYS T7/ColEI Ampicillin
PCH-MBP-DM N and C TERMINAL CYS T7/ColEI Ampicillin
PCH-MBP-DM S114C/N TERMINAL CYS T7/ColEI Ampicillin
PCH-MBP-DM S263C/N TERMINAL CYS T7/ColEI Ampicillin
PCH-MBP-DM A52C/S114C T7/ColEI Ampicillin
PCH-MBP-DM A52C/S263C T7/ColEI Ampicillin
PCH-MBP-DM A52C/S303C T7/ColEI Ampicillin
PCH-MBP-DM A52C/D95C T7/ColEI Ampicillin
PCH-MBP-DM D65C/K175C T7/ColEI Ampicillin
PCH-MBP-DM D30C/P298C T7/ColEI Ampicillin
PCH-MBP-DM S73C/P298C T7/ColEI Ampicillin
PCH-MBP-DM P298C/T345C T7/ColEI Ampicillin
PCH-MBP-DM A52C/A312C T7/ColEI Ampicillin
PCH-MBP-DM A52C/P298C T7/ColEI Ampicillin
PCH-MBP-DM A134C/P298C T7/ColEI Ampicillin
PCH-MBP-DM K175C/P298C T7/ColEI Ampicillin
PCH-MBP-DM S-(Pro)10-C T7/ColEI Ampicillin
PCH-MBP-DM C-(Pro)10-C T7/ColEI Ampicillin
PCH-MBP-DM D30C/S73C T7/ColEI Ampicillin
PCH-MBP-DM D30C/A134C T7/ColEI Ampicillin
PCH-MBP-DM D30C7K175C T7/ColEI Ampicillin
PCH-MBP-DM D30C/A312C T7/ColEI Ampicillin
PCH-MBP-DM D30C/T345C T7/ColEI Ampicillin
PCH-MBP-DM A21C T7/ColEI Ampicillin
PCH-MBP-DM K34C T7/ColEI Ampicillin
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Plasmid Promoter/Origin Selection marker
PCH-MBP-DM K42C T7/ColEI Ampicillin
PCH-MBP-DM K46C T7/ColEI Ampicillin
PCH-MBP-DM K88C T7/ColEI Ampicillin
PCH-MBP-DM K127 T7/ColEI Ampicillin
PCH-MBP-DM A141C T7/ColEI Ampicillin
PCH-MBP-DM K170C T7/ColEI Ampicillin
PCH-MBP-DM K179C T7/ColEI Ampicillin
PCH-MBP-DM A190C T7/ColEI Ampicillin
PCH-MBP-DM K202C T7/ColEI Ampicillin
PCH-MBP-DM A269C T7/ColEI Ampicillin
PCH-MBP-DM K277C T7/ColEI Ampicillin
PCH-MBP-DM K295C T7/ColEI Ampicillin
PCH-MBP-DM K326C T7/ColEI Ampicillin
PCH-MBP-DM K362C T7/ColEI Ampicillin
PCH-MBP-DM L113C T7/ColEI Ampicillin
PCH-MBP-DM I161S T7/ColEI Ampicillin
PCH-MBP-DM P298C T7/ColEI Ampicillin
PCH-MBP-DM A312C T7/ColEI Ampicillin
PCH-MBP-DM D30C T7/ColEI Ampicillin
PCH-MBP-DM L147C T7/ColEI Ampicillin
PCH-MBP-DM A52C/W230C T7/ColEI Ampicillin
PCH-MBP-DM A52C/M321C T7/ColEI Ampicillin
PCH-MBP-DM A52/S233C T7/ColEI Ampicillin
PCH-MBP-DM A52/A141C T7/ColEI Ampicillin
PCH-MBP-DM K34C/K141C T7/ColEI Ampicillin
PCH-MBP-DM K34C/A190C T7/ColEI Ampicillin
PCH-MBP-DM K34C/A202C T7/ColEI Ampicillin
PCH-MBP-DM K34C/K362C T7/ColEI Ampicillin
• The following positions were not active upon mutation and could not be purified
via affinity purification: S114C, W230C(reported to have reduced affinity to mal-
tose), and S233C(reported to have reduced affinity to maltose).
• The following positions were refolding defective after labelling : S263C, A303C,
S73C and A134C.
• The following positions were not amenable for labelling: the N-terminal and the
C-terminal Cys residues.
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3.3 Molecular Cloning Methods
3.3.1 Preparation and Transformation of E. coli competent
cells
For preparation of chemically-competent E. coli cells, a single colony was used to inoc-
ulate 500 ml LB medium (including antibiotic, if applicable) and grown to an optical
density (OD600) of 0.25− 0.5 at 37◦C. The cells were then chilled on ice for 15 min and
harvested at 5000 × g for 10 min at 4◦C. The cell pellet was washed with 80 ml ice-cold
Ca/glycerol buffer (10 mM PIPES, 60 mM CaCl2, 15 % glycerol; pH 7.0, adjusted with
NaOH, and filter-sterilized) once and incubated with additional 80 ml Ca/glycerol buffer
on ice for 30 min. Finally, the cells were pelleted and resuspended in 6 ml of Ca/glycerol
buffer. 100 µl aliquots were frozen in liquid nitrogen and stored at −80◦C. For transfor-
mation, approx. 50µl competent cells were mixed with 0.05 − 0.2 µg plasmid DNA or
1− 5 µl ligation reaction and incubated on ice for 15 min. The cells were heat-shocked
at 42◦C for 90 s and subsequently placed on ice for 2 min. 1 ml of LB medium was
added and the cells were shaken at 37◦C for 1 h. The cell suspension was then plated on
selective plates and incubated at 37◦C, until colonies had developed (typically 10 − 16
h).
Alternatively, electroporation was applied to improve the transformation efficiency. Elec-
trocompetent cells were prepared as follows: 500 ml bacterial culture was grown to an
optical density (OD600) of 0.8 in LB medium at 37◦C. The cells were washed carefully
with 250 ml ice-cold sterilized water for two times and finally the cells were pelleted and
resuspended in 2 ml of ice-cold 10% glycerol. 40 µl aliquots were frozen in liquid nitrogen
and stored at −80◦C. For electroporation transformation, competent cells (40 µl) were
mixed with 1 − 2 µl plasmid DNA (or ligation product) and transferred into a 0.2 cm
Gene Pulser cuvette. The electroporation was done at 2.5 kV, 25 µFD and 200Ω settings
with a Gene Puser II elecporation device. The transformed cells were allowed to recover
in 1 ml of SOC medium with 225 rpm shaking at 37◦C for 1 h. The cell suspension was
then plated on selective plates and incubated until colonies had developed same as in
the previous case.
3.3.2 Plasmid Purification
LB medium containing the appropriate antibiotic was inoculated with a single E. coli
colony harboring the DNA plasmid of interest and incubated for 8− 16 h at 37◦C with
shaking. Plasmids were isolated using the QIAprep Spin Miniprep Kit or QIAGEN
Plasmid Midi Kit (Qiagen) according to the manufacturer’s instructions.
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3.3.3 PCR Amplification
PCR (polymerase chain reaction) mediated amplification of DNA was performed accord-
ing to a standard protocol with minor modifications:
DNA Template: 50 ng (plasmid DNA)
Primers: 20 pmol each
dNTPs: 200 µM each
Pfu DNA Polymerase: 2.5 U
Polymerase buffer: 1 x
Additives: 3− 6 % DMSO if GC content was more than 50 %
Final volume: 50 µl
Cycling conditions 35 cycles
Initial denaturation: 94◦C, 5 min
Cycle denaturation: 94◦C, 30− 60 s
Annealing: approx. 55◦C, 30− 60 s
Extension: 72◦C, duration dependent on template length: 1 kbp/min.
Final Extension: 72◦C, 10 min.
Stored at 4◦C or −20◦C.
PCR products were further purified using the QIAquick PCR purification and gel
extraction kits (Qiagen) according to the manufacturer’s instructions.
3.4 DNA Restriction and Ligation
DNA restriction was performed according to the manufacturer’s instructions of the re-
spective enzymes. Typically, a 50µl reaction contained 1−2µl of each restriction enzyme
and 0.5−2 µg purified PCR product or 1−5 µg plasmid DNA in the appropriate reaction
buffer. Digested vector DNA was dephosphorylated with shrimp alkaline phosphatase.
For ligation, 100− 200 ng (approx.1− 2 µl) dephosphorylated vector DNA, 100− 200 ng
(approx.5− 10µl) DNA insert and 1µ l (100 U) T4 ligase were incubated in ligase buffer
at 25◦C for 1 h or, for increased efficiency, at 16◦C overnight. The ligation product was
transformed into competent E. coli DH5α cells as described.
3.5 DNA Analytical Methods
DNA concentrations were measured by UV absorption spectroscopy at λ = 260 nm.
A solution of 50µ g/ml of double stranded DNA in H2O exhibits approximately A260
nm = 1. Agarose gel electrophoresis was performed in TAE buffer (40 mM Tris, 1 mM
EDTA, 20 mM acetic acid) and 1 − 2% TAE-agarose gels, supplemented with 1µg/ml
ethidium bromide, at 4 − 6 V/cm. DNA sequencing was performed by Medigenomix
GmbH (Martinsried, Germany) or Sequiserve (Vaterstetten, Germany).
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3.6 Protein Purification
3.6.1 GroEL Expression and Purification
GroEL was purified with modifications to the protocol described by (Hayer-Hartl et al.,
1996). E. coli BL21 (DE3) Gold cells harboring the plasmid pCH-GroEL were grown in
6 l LB medium containing 100 mg/l ampicillin at 37◦C to OD600 of about 0.5. The induc-
tion was then proceeded by adding 1 mM final concentration of IPTG to the culture for
5−6 h. After harvesting the cultures by centrifugation for 30 min at 2500 x g, cells were
resuspended in 100 ml lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM DTT,
1 mM EDTA) and Complete protease inhibitor (1 tablet in 25 ml). The suspension was
further treated with lysozyme (1 mg/ml) and benzonase (approx.500 units). Lysis was
achieved by homogenization of the cell suspension in an EmulsiFlex C5 device kept on
ice. Cell debris were removed by ultracentrifugation for 60 min at 40, 000 x g, 4◦C and
with subsequent filtration (0.2 µm) for clearance of the supernatant. The supernatant
was applied to a 400 ml DE52 column attached to an AKTA Explorer chromatography
system. After washing with two column volumes of the lysis buffer, a NaCl gradient was
elevated to 0.6 M in five column volumes. The GroEL containing fractions were collected
and dialyzed in 5 l lysis buffer overnight at 4◦C. The deslated pool was applied into a 20
ml MonoQ column, eluted in 30 mM Tris-HCl pH 7.5, 1 mM DTT, 1 mM EDTA with
a NaCl gradient from 0 to 0.5 M. Fractions were collected and dialyzed against 30 mM
Tris-HCl pH 7.5, 30 mM NaCl, 1 mM DTT and 1 mM EDTA. The sample was then
applied to a 4 × 5 ml Heparin Sepharose column (HiTrap Heparin) and eluted with 30
mM Tris-HCl pH 7.5 with a NaCl gradient from 0 to 0.5 M NaCl. GroEL-containing
flow through was collected and concentrated to less than 5 ml in Centriprep concentra-
tors.Eventually the concentrated sample was applied to a Sephacryl S 300 (XK 26/60)
size exclusion column equilibrated in 30 mM Tris-HCl pH 7.5, 30 mM NaCl, 1 mM DTT,
1 mM EDTA and 10 % glycerol. GroEL oligomer (approximate size 800 kDa) fractions
were collected and concentrated to approx. 35 mg/ml (equivalent to 44 µM of GroEL
oligomer). And aliquots were flash frozen in liquid N2 and stored at −80◦C. Total yield
of GroEL was typically approx 600 mg.
3.6.2 GroES Expression and Purification
The expression and purification of GroES was similar as GroEL as described above, in-
cluding the induction, lysis and spin conditions. The supernatant was applied to a 400
ml DE52 column attached to an AKTA Explorer chromatography system. After washing
with two column volumes of the above buffer, a NaCl gradient was increased upto 0.5 M
in five column volumes. And GroEL containing fractions were collected and dialyzed in
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5 l lysis buffer overnight at 4 o C. The deslating pool was applied into a 20 ml MonoQ
column. Proteins were eluted in 30 mM Tris-HCl pH 7.5, 1 mM DTT, 1 mM EDTA
and a NaCl gradient from 0 to 0.5 M. GroES containing fractions were collected and
concentrated to less than 5 ml in Centriprep concentrators. Eventually the concentrated
sample was applied to a Sephacryl S 200 (XK 26/60) size exclusion column equilibrated
in 30 mM Tris-HCl pH 7.5, 30 mM NaCl, 1 mM DTT, 1 mM EDTA and 10 % glycerol.
GroES oligomer (approximate size 70 kDa) fractions were collected and concentrated to
approx. 15 mg/ml. Aliquots were frozen in liquid N2 and stored at −80◦C. Total yield
of GroES was typically about 400 mg.
3.6.3 Expression of MBP and MBP Mutants and Purification
MBP and MBP mutants were purified using an amylose affinity column (New England
Biolab). E. coli BL21 (DE3) Gold cells harboring the plasmid pCH-MBP wild-type and
pCH-MBP mutants were grown in 2l LB medium containing 100 mg/l ampicillin at 37◦C
to OD600 of approx. 0.9. The induction was then proceeded by adding 0.2 mM final
concentration of IPTG to the culture for 12−16 h at 25◦C. After harvesting the cultures
by centrifugation for 30 min at 2500 X g, cells were resuspended in 100 ml amylose
buffer (50 mM Tris-HCl pH 7.5, 20 mM NaCl, 1 mM DTT, and 1 mM EDTA) and
Complete protease inhibitor (1 tablet for 100 ml). The same lysis and spin conditions
as GroEL purification were applied. The supernatant was further dialyzed in amylose
buffer to remove cellular maltose and slowly loaded on to a 50 ml amylose column. After
washing with 3 column volumes of amylose buffer, MBP was eluted with amylose buffer
containing 10 mM maltose. Fractions containing MBP were collected and dialyzed in 5
l amylose low salt buffer (20 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM DTT, and 1mM
EDTA) overnight at 4◦C then concentrated to 10 mg/ml. Aliquots were frozen in liquid
N2 and stored at −80 ◦C. Typical yield of MBP from 2 l culture was about 100 mg.
3.6.4 Thiol-Mediated Labelling of the Cys Constructs
Double cys constructs in which one of the positions was 298 could be labelled specifically
as this position shows a differential accessability in presence or absence of Maltose. MBP
Cys mutants (100 µM) were labelled in buffer La - PBS pH 7.8, 500mM malto-triose
(Sigma). for 2 hr at 25◦C in the presence of a 1.1 fold molar excess of the fluorophore
Atto 532 malemide, (ATTO -TEC,Inc.). Unbound fluorophore was removed using micro
NAP columns (Amersham Biosciences) equilibrated in PBS pH 7.8. Before the second
step labelling, the protein was denatured in Buffer-Lb 3.0 M GuHCl in PBS pH 7.8 and
incubated with Activated Thiol Sepharose (Amersham Biosciences) for 2 hours and the
singly labelled species were eluted with buffer Lb and 50mM DTT. Second step labeling
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was carried out at similar conditions with 2 fold molar excess of Atto 647N malemide,
(ATTO -TEC,Inc.) The coupling efficiency measured by the absorption of MBP (280 =
69mM−1cm−1), and Atto 532 (532 = 115mM−1cm−1) was more than 90%.
For stochastic labelling, the protein was labelled in buffer Lb with equimolar concen-
tration of both the dyes mixed together. The reaction was carried out for 2 hours at 25◦C
and the protein was desalted to remove any unbound dye using the micro NAP columns;
and concentration was determined using the above mentioned extinction coefficients.
3.6.5 Thiol-Mediated Labelling of GroEL and GroES
GroEL E315C and GroES 73C were used for thiol mediated labelling. GroEL or GroES
were labelled in buffer La - PBS pH 7.8, upon incubation with the dye with 1 : 1 Molar
ratio for 2 hrs on ice. The excess unbound fluorophore was removed using micro NAP
columns (Amersham Biosciences) equilibrated in Buffer LS.
3.7 Protein analytical methods
3.7.1 Determination of Protein Concentration
Protein concentrations were determined spectrophotometrically by A280 (in 6 MGuHCl),
based on the theoretical extinction coefficient of the respective protein at λ=280 nm (Gill
and von Hippel, 1989) as calculated by the ProtParam tool at the ExPASy proteomics
server (http://www.expasy.org). Molar concentrations of chaperones are expressed for
the native state as oligomers and for DM-MBP as monomer.
3.7.2 SDS-PAGE
SDS-Polyacrylamide gels were prepared as follows: 4 % stacking gels and 10 %, 12 % or
15 % sepqrating gels were prepared according the following recipe:
% acrylamide (AA) 12 15 4
30 % AA, 0.8%bis-AA 8 ml 10 ml 1.3 ml
1.5 M Tris-HCl, pH 8.8 5 ml 5 ml -
0.5 M Tris-HCl, pH 6.8 - - 2.5 ml
10 % SDS 0.2 ml 0.2 ml 0.1 ml
Water 1.8 ml - 6.1 ml
TEMED 10 µl 10 µl 5 µl
APS 50 µl 50 µl 100 µl
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SDS-PAGE was performed using a discontinuous buffer system (Laemmli, 1970) in
BioRad Mini-Protean 3 electrophoresis chambers employing a constant current of 30
mA/gel in 50 mM Tris-Base, 380 mM glycine, 0.1 % SDS (pH 8.3). Protein samples
were prepared for SDS-PAGE by mixing with 5x Laemmli buffer (Laemmli, 1970) (final
concentration of 1x Laemmli buffer: 60 mM Tris-HCl, pH6.8, 1% SDS, 10% glycerol,
0.01% Bromophenol blue, 0.1 mM β-mercaptoethanol) and boiling samples at 95◦C
for 3 − 5 min before loading onto a gel. After electrophoresis, gels were stained with
Coomassie blue staining solution (0.1 % Coomassie brilliant blue R-250, 40 % ethanol,
7 % acetic acid) for 1 h or longer and destained in 20 % ethanol, 7 % acetic acid.
3.8 Biochemical and Biophysical Methods
Protein refolding reactions for ensemble studies containing chaperones (when present)
were carried out with the following molar concentration ratios of chaperones to substrate:
1 substrate (monomer) : 2 GroEL (tetradecamer) : 4 GroES (heptamer), unless otherwise
specified.
3.8.1 MBP Refolding
MBP-DM and its derivative cys mutants (12.5 µM) were denatured in 3 M GuHCl, 5
mM Tris-HCl, pH 7.5, 20 mM KCl (Buffer B) at 25◦C and refolded upon 50-fold dilution
into low salt buffer - Buffer A (20 mM Tris-HCl, pH 7.5, 20 mM KCl, 5 mM Mg(OAc)2)
in the absence or presence of chaperones. GroEL/GroES assisted refolding was initiated
at 25◦C by the addition of 5 mM ATP. Intrinsic tryptophan fluorescence was monitored
on a Fluorolog 3 Spectrofluorometer (Spex) with an excitation wavelength of 295 nm
(slit width 2 nm) and an emission wavelength of 345 nm (slit width 5 nm) (Chun et al.,
1993).
3.8.2 Stopped-Flow Experiments
All stopped-flow experiments were done by using an Applied Photo Physics SX.18MV
stopped-flow reaction analyzer instrument, with a 1 : 1 mixing ratio at 25◦C. The ex-
citation wavelength used was 515 nm with a cut-off filter of wavelength 530 nm. For
anisotropy measurements dual channel measurements were done using photomultiplier
tubes (PMTs) measuring the parallel and the perpendicular measurements simultane-
ously.
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3.8.3 Preparation of GroEL-ADP-GroES ”Bullet”
1mM ADP was added to buffer A containing 10µM of GroEL and 15µM of GroES. The
excess ADP was removed using micro bio-spin columns with a cut-off of 40KDa (Biorad)
equilibrated in buffer A. The obtained solution was diluted to 1µM GroEL. The integrity
of the bullet was tested in presence and absence of ATP by observing FRET between
Atto-532 labelled GroEL and Atto-647N labelled GroES.
3.8.4 Equilibrium Unfolding of MBP
The equilibrium unfolding of MBP (0.25 µM) was performed at 25◦C in buffer A con-
taining 0 − 1.5 M GuHCl and followed by intrinsic tryptophan fluorescence at 345 nm.
Equilibrium unfolding curves fit a two state transition.
3.8.5 Sample for Single Molecule Spectroscopy of Chaperonin-
Substrate Complex
Substrate and GroEL/SR-EL Complexes were formed by diluting double labelled de-
natured MBP-DM in buffer B (3µM ) 100 fold into buffer A containing GroEL/EL-SR
(3µM). These complexes were then analyzed for their diffusion time through the probe
volume by fluorescence correlation spectroscopy.
This solution was then diluted in buffer A 500 times for spFRET by burst analysis. The
picomolar(pM) concentrations of labelled protein (the final concentration of chaperonin
was 3µM) ensure that the probability of more than one molecule in the probe volume at
the same time is negligible.
3.8.6 Sample Preparation for Single Molecule Spectroscopy of
GroEL-Cycling
After initiating GroEL/GroES/ATP mediated refolding of DM-MBP(52−298) and DM-
MBP (30 − 312), the reaction was terminated using EDTA and apyrase at 90sec and
300sec. Native and unbound protein that may have been formed during the course
of the reaction was removed using amylose resin which would bind native protein and
was passed through a 100kD centricon to remove any DM-MBP that remains unbound
to GroEL (Fig 3.1). Sample was also prepared to check the distribution of GroEL
bound substrate when GroEL binds to the substrate already undergoing spontaneous
refolding. GroEL was added to an aliquot of spontaneously refolding double labelled
DM-MBP(52 − 298) at similar time points and the sample was processed in a similar
fashion to remove and any native and unbound protein.
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Figure 3.1: Schematic Representation of the Method. Sample Preparation for Investigating the
Bound State upon GroEL Cycling and Spontaneous Refolding.
3.8.7 Calculation of FRET Efficiencies Using Burst Analysis
The FRET efficiencies were determined using burst analysis (Deniz et al., 1999). The
single molecule diffusing through the confocal volume emits a burst of photons, which
were counted as significant, when the number of photons in a 2ms time bin was larger
than a threshold of 17 photons, after the green excitation. For ensuring the presence
of an active acceptor, additional 12 photons must be detected after the red excitation.
FRET efficiencies were calculated as discussed in the introduction using the equation:
fE =
FAD
αFDA + FAD
where α = (φAηA/φDηD) corrects for differences in the quantum yields (φ) and the
detection efficiencies (η) of the donor and acceptor, respectively. This factor was deter-
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mined as described in (Lee et al., 2005) to be 0.9 for Atto532 and Atto647N labelled to
MBP-DM. Average values of crosstalk and direct excitation were subtracted from the
fluorescence signals.
3.8.8 Determination of the Forster Radius
The Forster radius R0 for the FRET-pair Atto532/647N labelled to MBP-DM was calcu-
lated with the program PhotChemCad using n=1.33 for the index of refraction, κ2 = 2/3
for the orientation factor and Atto647 = 1.5× 105l/mol cm for the absorption coefficient.
The absorption-/emission-spectra were taken of the bound fluorophores, the quantum
yield of the donor was determined by comparing the quantum yield of the free dye in
water (0.9 given by Atto-Tec) and the bound fluorophore to be φ532 = 0.4.
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Chapter 4
Results
4.1 Sp-FRET Distribution of Double labelled DM-
MBP
In order to study the conformational heterogeneity of unfolded protein when bound to
GroEL or SR-EL, we used DM-MBP which is known to be an in vivo substrate of GroEL
and in vitro exhibits acceleration in refolding rate in presence of the GroE system (Tang
et al., 2006). We constructed a series of double cysteine mutants on the background
of DM-MBP to facilitate thiol specific double labelling of the protein (Fig.4.1A). The
double labelling of these proteins for single molecule measurements were carried out sto-
ichiometrically as PIE-spFRET1 technique is capable of analyzing only double-labelled
molecules from a pool of heterogeneously labelled samples. The cysteins engineered at
various positions e.g. 30, 52, 175, 298, and 312 did not affect GroEL/ES/ATP assisted
folding rate of the proteins as examined by Trp fluorescence (Tang et al., 2006), which
reports the fraction of refolded protein.
As Trp fluorescence is highly quenched in the double labelled proteins, the fraction of
folded proteins formed was quantified by performing the refolding reaction in presence or
absence of maltose and monitoring the fluorescence of Atto-532. DM-MBP(52−298) and
DM-MBP(175 − 298) were labelled preferentially at position 52 and 175 with Atto-532
respectively in presence of maltose and 298 was labelled with Atto-647N after maltose
was removed from the labelling reaction. Position 298 in the double labelled protein is
sensitive to maltose binding and hence this can be used to estimate the fraction of native
protein. Maltose-bound double-labelled protein has about 2.5-fold higher fluorescence
compared to maltose-free native protein. This may be due to change in the environment
of the acceptor from hydrophillic to hydrophobic brought upon by binding of maltose
or by its quenching. The ratio of the fluorescence intensities of the refolding in presence
1Sp-FRET measurements were done together with Barbara K. Mueller.
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Figure 4.1: Representation of the Cys-Mutants Used and Their Folding Behaviour. Ribbon
diagram of the structure of MBP (spurolino et al, 1991; pdb 1OMP; PyMol) with the positions for
engineered cysteine into the protein shown as space fill structures. Refolding of DM-MBP(52−298) (B)
and DM-MBP(175− 298) (C) was initiated upon 50-fold dilution of the proteins (12.5µM) unfolded in
3M GuHCl at 25◦C into buffer A. Chaperonin assisted rates were obtained by dilution of the unfolded
proteins in buffer A containing 3 µM of chaperonin, 6 µM of GroES and 2mM of ATP.
and absence of maltose was used to quantitate the fraction of protein capable of binding
maltose (Fig.4.1B and C).
Protein Spontaneous Fold-
ing Rates(X 103)
GroEL/ES Fold-
ing Rates(X 103)
SR-EL/ES Fold-
ing Rates(X 103)
DM-MBP(52− 298) 0.66± 0.04 3.8± 0.05 3.9± 0.08
DM-MBP(52− 298)SL 0.71± 0.05 3.94± 0.08 4.6± 0.14
DM-MBP(52− 298)DL 0.77± 0.06 5.27± 0.12 5.3± 0.11
DM-MBP(175− 298) 0.7± 0.05 4.2± 0.03 4.6± 0.12
DM-MBP(175− 298)SL 0.8± 0.06 4.7± 0.1 4± 0.16
DM-MBP(175−298)DL 0.73 + 0.07 4.2± 0.07 4.1± 0.05
Rate of formation of native protein was similar for both labelled and unlabelled
proteins indicating that the introduction of label does not change the spontaneous as
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well as the chaperonin assisted folding reaction. All the refolded proteins reached the
native state as monitored by their ability to bind maltose (Fig.4.2).
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Figure 4.2: Single Molecule Distribution of the Maltose Bound and Maltose Free Form
of DM-MBP(175 − 298). Sp-FRET distribution of the native state of DM-MBP(175 − 298)without
maltose (inset) changes upon binding of maltose as shown by a shift in the peak FRET efficiency.
The distance distributions obtained for the native state for these constructs as well
as others (described in appendix) correspond well with the distances calculated from the
crystal structure (Tabulated below) of MBP (1OMP, (Spurlino et al., 1991)) acting as a
control for the validity of the Sp-FRET method for this protein. The Fo¨rster radius of
the dye pair when coupled to protein was found to vary between 45− 50A˚.
Construct Distance (Crystal
Structure) (in A˚)
Distance Refolded
(FRET) (in A˚)
Distance Unfolded
(FRET) (in A˚)
52-298 33 35 67
175-298 32 34 61
30-175 40 41 52
30-134 61 61 60
52-312 39 40 74
73-298 32 32 65
134-298 37 38 58
The refolded proteins also show distributions with high EFRET identical to that of
native state indicating that the labelled proteins are able to reach the native state upon
refolding.
The distance distributions obtained after spontaneous and GroEL/GroES-assisted
refolding were indistinguishable (Fig.4.3 B and C) and were in good agreement with the
distances calculated from the MBP crystal structure (as seen form the Table above).
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Figure 4.3: Sp-FRET Measurements of Different Cys Variants of Double Labelled
DM-MBP Sp-FRET measurements of double-labelled DM-MBP(52 − 298) (left), DM-MBP(175 −
298)(center) and DM-MBP(30 − 312)(right). FRET efficiency distribution is shown for the protein
unfolded in 3M GuHCl (A) ,spontaneously refolded protein (B) and GroEL refolded protein (C).
Fully denatured DM-MBP in solution exhibited similarly low EFRET values for all three
cysteine pairs measured (Fig.4.3A).
This denatured conformation was compared with that of the protein bound to GroEL
upon dilution from denaturant.
4.2 Conformational Heterogeneity of GroEL Bound
Protein
Denatured protein was diluted into GroEL containing buffer. Interestingly, a bimodal
EFRET distribution was observed for the GroEL-bound protein (Fig.4.4 A). In the case of
DM-MBP(52− 298), a broad distribution of molecules (approx. 60 % of total) centered
around a high EFRET of approx. 0.7, comparable in compactness to the native state,
whereas another population of molecules (about 40% of total) exhibited a more narrow
distribution with an EFRET of 0.06, more expanded than the average conformational
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distribution of the fully denatured protein (Fig.4.4, left).
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Figure 4.4: Sp-FRET Measurements of Chaperonin bound DM-MBP) Sp-FRET measure-
ments of double-labelled DM-MBP(52−298) (left), DM-MBP(175−298) (center) and DM-MBP(30−312)
(right). GuHCl-denatured double labelled protein (3nM) at 25◦C was diluted 50-fold into buffer A con-
taining 3µM of GroEL (A) or SR-EL (B) to obtain the chaperonin bound distributions.
Qualitatively similar results were obtained for DM-MBP(30−312), but in this case a
greater fraction of GroEL-bound molecules (about 65% of total) populated the expanded
conformation (Fig.4.4, right). DM-MBP(175− 298) on the other hand exhibited a very
broad EFRET distribution when bound to GroEL, with only a small fraction of molecules
being as expanded as in denaturant (Fig.4.4, center). To rule out the possibility that
there are unbound unfolded species in the sample which exhibits the low FRET effi-
ciency distribution, the measurements were performed with two to three times higher
concentrations of GroEL or SR-EL which resulted in similar distributions.
More compact conformational distribution were generally observed when the proteins
were bound to the GroEL single-ring mutant, SR-EL (Fig.4.4). This effect correlated
with a lower affinity of SR-EL for unfolded DM-MBP compared to wild-type (WT)
GroEL. With SR-EL, FRET efficiencies show a single distribution having a peak with
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high FRET efficiency (62%) (Fig.4.4B). Since SR-EL has a lower binding affinity for
DM-MBP than GroEL (shown in later section), absence of the expanded state in the
SR-EL-DM-MBP complex rules out the possibility that the open state seen with GroEL
is an artifact of unbound unfolded species. These experiments were also reproduced by
ensemble steady state FRET measurements which showed that FRET efficiency of the
protein bound to GroEL has lower efficiency than the one bound to SR-EL.
The GroEL and SR-EL bound distributions differ from each other where the distri-
bution of SR-EL bound form is broader and shifted towards higher FRET efficiency state
than GroEL bound form. DM-MBP(175C-298C) on the contrary exhibits very similar
distributions when bound to GroEL (Fig.4.4A, center) or SR-EL (Fig.4.4B, center) and
the expanded conformation is nearly absent. The difference in the proportion of ex-
panded and compact conformations for the three different distances monitored suggest
that the opening up observed for DM-MBP is a local phenomenon and that there is
considerable heterogeneity in either the GroEL or SR-EL bound state representing an
ensemble of dynamic states. Importantly, ensemble FRET measurements upon dilution
of DM-MBP from denaturant demonstrated that the molecule collapses to native-like
compactness within milliseconds from FRET efficiency of approx. 10% (Fig.4.5 red).
Subsequent addition of GroEL resulted in a rapid expansion with kinetics similar to
binding, as shown for DM-MBP(52− 298) (Fig.4.5, black).
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Figure 4.5: Binding Kinetics of the Refolding Protein to GroEL as Observed by Stopped-
Flow Analysis. Refolding of DM-MBP(52− 298) was initiated by 25 fold dilution of DM-MBP(52−
298), denatured in 1.5M GuHCl, into refolding buffer in a stopped-flow apparatus and is followed by
change in FRET efficiency. To check the kinetics of GroEL binding and expansion of a refolding protein,
spontaneously refolding DM-MBP(52 − 298) was mixed with buffer only (red) and buffer containing
GroEL(black).
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4.3 Diffusion Coefficients of Different States of DM-
MBP
D = diffusion coefficient
k = Boltzman constant
T = temperature(in K)
η = viscosity
Rh = hydrodynamic radius
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Figure 4.6: Autocorrelation Curve of the Various States of the Labelled Protein for Com-
paring Diffusion Coefficients. A) Diagrammatic representation of the Fluorescence Correlation Spec-
troscopy of the Chaperonin-Substrate Complexes. B) The autocorrelation data for Atto-532 labelled
DM-MBP in the various states were obtained by fluorescence correlation spectroscopy. The residence
times follow a good correlation with the hydrodynamic radii of DM-MBP or DM-MBP/chaperonin
complex, with GroEL bound protein exhibiting the highest residence time and the native protein the
lowest.
Using Fluorescence Correlation Spectroscopy (FCS), the diffusion coefficient of pre-
formed complexes of DM-MBP-GroEL and DM-MBP-SREL as well as for free native
and unfolded DM-MBP could be determined. All these curves could be fit to a single
component model suggesting that in the measurements with GroEL/SR-EL, most of the
observable molecules are bound to GroEL/SR-EL(Fig.4.6).
To rule out that the bimodal distribution observed in the FRET analysis for the
GroEL-substrate complex is due to two substrate proteins bound on each side of the
GroEL double ring, Fluorescence Cross-Correlation Spectroscopy (FCCS) was performed
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Figure 4.7: The autocorrelations and the cross-correlation of the dyes as observed in FCCS.
Auto and cross correlation curve of Single labelled DM-MBP(52C). Two single labelled proteins, 1.5nM
DM-MBP(52C) labelled with Atto-532 (DM-MBP(52C)-Atto532) and 1.5nM DM-MBP(52C) labeled
with Atto-647N (DM-MBP(52C)-Atto647N) were unfolded together in 3M GuHCl. This was then
diluted 50 fold in buffer A containing 3µM GroEL.
on a mixture of unfolded donor labelled DM-MBP (52C) and acceptor labelled DM-MBP
(52C) with GroEL. If there are two differently labelled proteins each bound onto either
side of the tetra-decamer, they will diffuse simultaneously through the probe volume and
a cross correlation between the signal of the two dyes should be observed. The absence
of cross-correlation between the two dyes indicates that the proteins did not co-migrate
during diffusion, ruling out the possibility of two substrate molecules binding to one
molecule of GroEL (Fig.4.7).
Inherent heterogeneity in GroEL preparations has been reported (Panda and Horowitz,
2002) and to rule out the possibility of heterogeneity in preparation being the reason for
obtaining a bimodal distribution with GroEL, experiments were repeated with different
batches of GroEL preparation which exhibited identical distributions.
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4.4 Anisotropy Decay for Various DM-MBP Labelled
Proteins
It is known that the relative orientation of the donor and the acceptor dyes plays an
important role in FRET (Dale, 1979). To judge the conformational flexibility of the dyes,
time resolved anisotropy decays were obtained for all the donor and acceptor labelled
proteins in complex with GroEL (Tabulated 4.8) which exhibit fast phase of anisotropy
decay compared to the excited state lifetime of the dye at all the positions. This suggests
that there is considerable flexibility of the dye molecules during its excited state lifetime
and thus rules out the possibility that a biased orientation of acceptor or donor resulted
in the bimodal distributions or influences the measured FRET efficiencies.
Figure 4.8: Anisotropy values at the different engineered Csy positions for Atto-532 and
Atto-647N.The table reports fundamental anisotropy (ro), fast (τ f) and slow (τs) phase of anisotropy
decay and their respective amplitudes (αf and αs) at the different positions.
4.5 Polyproline Fusion Protein - A Spectroscopic
Ruler.
Control experiments were performed with a 10 residue poly-proline ruler at the C-
terminus of DM-MBP. Two cysteines were positioned at the N-terminus and C-terminus
of the poly-proline stretch and were labelled with the same donor and acceptor dyes
(Fig.4.9). The two positions were labelled stoichiometrically by addition of both Atto-
532 and Atto-647N at 1 : 1 molar concentrations. PIE-SpFRET was used to analyze only
double labelled molecules in the heterogeneous population. Both the samples (GroEL or
SR-EL) show a single distribution with similar peak position and width, indicating that
68 4.5. POLYPROLINE FUSION PROTEIN - A SPECTROSCOPIC RULER.
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Figure 4.9: Control Experiments with Sp-FRET Using 10 Residue Polyproline Ruler. A)
The construct of DM-MBP-Cys-(Pro)10-Cys was designed as shown schematically. The preformed
polyproline-chaperonin complex was mixed with ATP or ADP with the final concentration of 2mM
of nucleotide, 3µM of chaperonin and 60pM of the substrate protein in buffer A. 3nM of the labelled
protein (DL-DM-MBP-polyPro) was unfolded in buffer B and then diluted 50 fold in buffer A containing
3µM GroEL(B) or 3µM SR-EL(C). 2mM ATP (D) or 2mM ATP and 3µM of GroES (E) was added to
SR-EL/ (DL-DM-MBP-polyPro).
GroEL or SR-EL as such does not affect the distribution. The peak efficiency did not
show any significant difference in refolding buffer. To rule out the possibility that either
addition of ATP or the encapsulation of the protein causes a significant change in the
properties of the dyes, measurements were also done under those conditions. Near iden-
tical distribution confirmed that efficiency measured for the different states are relevant.
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4.6 Conformational Dynamics of GroEL Bound Sub-
strate Upon Nucleotide Binding
It has been earlier proposed that GroEL brings about unfolding of substrate upon nu-
cleotide binding, facilitating removal of kinetic traps and thus resulting in more efficient
refolding (Shtilerman et al., 1999). To test this hypothesis, the bound state conformation
of DM-MBP cysteine mutants double labelled with FRET pairs were used to probe the
conformational changes upon addition of nucleotides. DM-MBP(52− 298) GroEL com-
plexes were preformed in the presence of ATP to investigate these effects. With 2mM
ATP, the bimodal distribution of DM-MBP (52− 298) is shifted to a single distribution
at high FRET efficiency (Fig.4.10B). Similarly compact state is also obtained when ADP
(Fig.4.10C) is used instead of ATP. Since GroEL hydrolyses ATP much faster than the
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Figure 4.10: Single Molecule FRET Distribution of Chaperonin Bound Protein Complex
in Presence of Nucleotide. The preformed substrate-chaperonin complex was mixed with ATP or
ADP with the final concentration of 2mM of nucleotide 3µM of chaperonin and 60pM of the substrate
protein in buffer A. Substrate-capture-complex of DM-MBP(52 − 298) and WT GroEL(A) with ATP
(B) or ADP (C). DM-MBP(52− 298)complexed with GroEL D398A (D) or GroEL D87K (E); or with
WT GroEL,ATP and EDTA (F)
time-scale of the measurements, an ATP hydrolysis defective mutant of GroEL (GroEL-
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4.6. CONFORMATIONAL DYNAMICS OF GROEL BOUND SUBSTRATE UPON
NUCLEOTIDE BINDING
D398A) was used to delineate the effect of ATP binding from hydrolysis and it was
found to be identical to that of WT-GroEL (Fig.4.10 D and A respectively). Therefore
WT-GroEL was used for further experiments. Control experiments were performed with
an ATP binding deficient mutant of GroEL, GroEL (D87K), which does not exhibit
similar shift in conformation upon addition of ATP or ADP (Fig.4.10F) proving that
ATP binding is essential for the shift in conformation. Since GroEL-bound DM-MBP
(52− 298) shows similar distributions when bound to GroEL or GroEL (D398A) in the
presence of ATP, and in the presence of ADP, it is concluded that ATP or ADP binding
and not hydrolysis is important for this shift in conformation.
This shift is reversible upon dilution of nucleotide or by addition of EDTA indicating
that the structure of the substrate protein is dynamic and interconvertible between the
expanded and the compact conformation. Since SR-EL in nucleotide-free state exhibits
only the more compact state, no significant difference could be observed upon binding
of ATP or ADP.
DM-MBP(30 − 312), which shows higher percentage of extended state when bound
to GroEL as compared to that from SR-EL. This may be because of lower affinity of
SR-EL for DM-MBP which in turn may be due to different orientation of the apical
domains. The proportion of this expanded state also decreases, upon addition of ATP
and ADP (Fig.4.11, left). In case of SR-EL/DM-MBP(175 − 298) there is no distinct
difference as compared to that of GroEL bound distribution. Interestingly, it is observed
that the distributions are different in ADP and ATP bound states in both GroEL and
SR-EL, indicating that GroEL has distinct conformations when bound to ATP or ADP
and this is reflected in the subtle differences in conformation of the bound protein. This
conformational difference may result from the load presented by the substrate protein
on the apical domain of GroEL where the binding energy of the γ-phosphate group
is essential for effecting a conformational change in presence of the substrate protein
(Motojima et al., 2004).
DM-MBP(175−298) which exhibits compact distribution in GroEL and SR-EL bound
form does not undergo any significant change in distribution upon addition of ATP or
ADP(Fig.4.11, right). The fact that the conformational distribution of DM-MBP can be
regulated by ATP concentration suggests that the two distributions result as a function
of GroEL conformation, which is known to be regulated by ATP or ADP. The binding
affinity of GroEL for unfolded protein is higher in nucleotide-free state than in the nu-
cleotide bound state which in turn is known to be modulated by ATP or ADP induced
change in hydropobicity of substrate binding site (Kim et al., 2005). This would indicate
that the expanded state of the unfolded protein results due to the binding of the unfolded
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Complexes in presence of ATP
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Figure 4.11: Single molecule FRET Distribution of Chaperonin Bound Protein Complex in
Presence of ATP and ADP. The preformed substrate-chaperonin complex was mixed with ATP or
ADP with the final concentration of 2mM of nucleotide, 3µM of chaperonin and 60pM of the substrate
protein in buffer A.
protein to high-affinity binding state of GroEL which is absent in SR-EL or nucleotide
bound state of GroEL. It is possible that even though we do not observe any expansion
event in nucleotide bound state of the chaperonin, expansion is facilitated upon GroES
binding to the GroEL-substrate-nucleotide complex.
4.7 Effect of GroES Binding on Chaperonin-Substrate
Complex
In order to investigate whether GroES binding to preformed SR-EL/DM-MBP/nucleotide
complex results in expansion of the protein, ADP and ATP were used to form the com-
plex. It was observed that the SR-EL/DM-MBP complex in the presence of ADP is able
to bind GroES but not refold the protein. This maybe due to a partial release of DM-
MBP into the cavity forming a SR-EL/DM-MBP/GroES unproductive ternary complex
in the presence of ADP as observed with ensemble FRET studies (see later section).
These ternary complexes with ADP and ATP were used to observe if during the course
of GroES binding, there is any unfolding event on the apical domain. We saw no signifi-
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Figure 4.12: Single Molecule FRET Distribution of the Ternary Complex Between SR-EL
Substrate Protein and GroES in Presence of ATP or ADP. The preformed substrate-chaperonin
complex was mixed with ATP or ADP with the final concentration of 2mM of nucleotide, 3µM of
chaperonin and 60pM of the substrate protein and 6µM of GroES in buffer A.
cant difference in the distribution of FRET efficiency of the SR-EL/DM-MBP/nucleotide
complex in case of the different constructs observed (Fig.4.12). Although, upon GroES
binding it was observed that the protein undergoes significant compaction.(Motojima
et al., 2004).
In the case of DM-MBP, we see a progressive collapse of the bound state onto the
GroEL and no subsequent opening up observable by this method and with this time res-
olution, after GroES binding. Therefore, we monitored the fast kinetics of this process
by following ensemble FRET on a stopped-flow apparatus. This technique was exploited
to resolve processes in the order of milliseconds which is much faster than what is ob-
servable in the Single-Molecule experimental set-up, which has a dead time of around
50sec.
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4.8 Stopped-Flow Ensemble FRET Analysis of Nu-
cleotide and GroES Binding
ATP binding precedes the binding of GroES in the GroEL reaction cycle and is known
to cause a 5− 10 degree clock-wise turning motion of the apical GroEL domains (Chen
et al., 1994). Moreover, steady-state single molecule FRET experiments showed that
DM-MBP assumed native-like compactness in the presence of nucleotide, and upon en-
capsulation by GroES (Fig.4.12). However, due to the limited time resolution, these
measurements could not detect a transient expansion of DM-MBP caused by GroES
binding. Therefore we, performed ensemble FRET measurements upon stop-flow2 mix-
ing of DM-MBP/SR-EL complexes with ATP or ATP/GroES.
Interestingly, for both DM-MBP(52−298) (Fig.4.13, black)and DM-MBP(175−298)
(not shown), addition of ATP alone resulted in a rapid, transient expansion of the bound
protein that was followed by compaction. No such expansion was detected upon addition
of ADP (Fig.4.13 red).
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Figure 4.13: Conformational Dynamics of the GroEL Bound Protein in Presence of Dif-
ferent Nucleotides. 100nM DM-MBP(52 − 298)/SR-EL complex was prepared by diluting 5µM of
unfolded DM-MBP(52 − 298) in buffer containing 1µM of SR-EL. This was taken in one syringe of
the stopped flow apparatus and mixed with an equal volume of buffer(blue), ADP(red), ATP(black) or
ADP-AlFx(green) to obtain the conformational change in DM-MBP upon binding of nucleotide to SR-
EL. These efficiencies plotted are not corrected for presence of inactive acceptors in the double-labelled
protein.
2Stopped-flow experiments were done together with Kausik Chakraborty.
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Figure 4.14: Conformational dynamics of the GroEL bound protein in presence of different
nucleotides and GroES. 100nM of DM-MBP(52−298)/SR-EL complex was mixed with equal volume
of buffer(blue), ADP and GroES(red), ATP and GroES (black) and ADP-AlFx and GroES(green) to
obtain the conformational change of DM-MBP upon encapsulation. To obtain the effect of GroES
binding to preformed DM-MBP(52−298)/SR-EL /ATP complex, the DM-MBP(52−298)/SR-EL/ATP
complex was preformed and mixed with equal volume of GroES (pink).
GroES binding to GroEL is associated with a dramatic 60 degree clock-wise turn and
an upwards motion of the GroEL apical domains, which may cause further stretching of
the substrate (Chen et al., 1994). However, GroES binding to DM-MBP/GroEL/ATP
complexes resulted in a rapid compaction of the bound protein (t1/2 approx. 500 msec),
concomitantly with its release into the GroEL cavity (Fig.4.14, pink). On the other
hand, when GroES was mixed with DM-MBP/GroEL complexes and GroES binding
was triggered by addition of ATP, transient expansion of the protein followed by com-
paction was again observed (Fig.4.14, black). These changes in efficiency can be taken
as the corresponding change in conformation of the protein itself and not and indirect
effect because of the change in the spectral properties of the dyes during the process, as
measurements with poly-proline construct showed no interference in determining FRET
efficiency of the bound and encapsulated protein in case of GroEL or SR-EL.
Thus, in the case of DM-MBP, local unfolding triggered by ATP-mediated apical do-
main movement is followed by a compaction, which is completed upon GroES-mediated
displacement of bound protein into the chaperonin cage. To address the question whether
ATP-mediated structural expansion of DM-MBP is a mechanistic requirement for sub-
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Figure 4.15: SR-EL and GroES Mediated Refolding Kinetics of DM-MBP in the Presence
of ATP and ADP-AlFx. Spontaneous refolding (blue) was initiated by diluting the unfolded protein
in buffer A; SR-EL mediated refolding of DM-MBP was initiated in presence of SR-EL/GroES/ATP
(red) or SR-EL/GroES/ADP-AlFx (black) and monitored by Trp fluorescence of DM-MBP.
sequent accelerated folding, we took advantage of the finding that a mixture of ADP
and AlFx, (Inobe et al., 2003) (made in situ by mixing NaF and KAl(SO4)2) mimics
the transition state of ATP hydrolysis (Chaudhry et al., 2004). ADP-AlFx produced a
similar degree of expansion of GroEL-bound DM-MBP as ATP but with approx. 50-fold
slower kinetics (Fig.4.13, green).
As a consequence, simultaneous addition of ADP/AlFx and GroES circumvented the
transient unfolding step, resulting in immediate compaction (Fig.4.14, green). Importantly,
under these conditions folding of DM-MBP within the GroES-enclosed cage of SR-EL
occurred with similar accelerated kinetics as in the presence of ATP (Fig.4.15). Similarly,
when ATP and GroES was added to SR-EL bound protein in the presence of 750mM
(NH4)2SO4, the transient unfolding before the encapsulation triggered compaction is
not seen (Fig.4.16). But even under these circumstances, the rate of refolding of DM-
MBP is the same as that carried out under usual buffer conditions. Thus, ATP-mediated
structural expansion is not a requirement for subsequent rapid folding, at least in the
case of DM-MBP.
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Figure 4.16: Conformational Dynamics of GroEL Bound Protein in the Presence of
(NH4)2SO4 Induced with ATP and GroES. SR-EL/GroES/ATP mediated refolding of DM-MBP
was initiated in the absence (blue) or presence of (NH4)2SO4 (red) as monitored with FRET .
4.9 GroEL Cycling and the Bound-State
It has also been proposed that iterative annealing of substrate protein might be able to
facilitate the refolding of substrate protein (Todd et al., 1996). To see how GroEL cycling
and rebinding affects the distribution of the bound state, GroEL assisted refolding was
initiated with ATP and then stopped at specific time points by addition of apyrase
and EDTA as described earlier (Brinker et al., 2001). DM-MBP-GroEL complexes were
purified as described in Materials and Methods and analyzed by SpFRET. They were
seen to have the same distribution at different time points after the initiation of the
refolding reaction (Fig.4.17). The small increase in the fraction of compact conformation
compared to binding to nucleotide free GroEL may be attributed to the presence of small
amount of ADP even after the treatment but the sample definitely does not contain a
higher proportion of expanded conformation.
More importantly, no observable change in conformational distribution is observed
between reactions stopped at 90 s and 300s. Considering that substrate protein would
have undergone 3-fold more cycling events at the end of 300s that at the end of 90sec,
would indicate that distribution of conformation of the bound state does not depend on
the number of times the protein has been through the GroEL cycle.
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Figure 4.17: Sp-FRET Distribution of GroEL DM-MBP(30−312) Complexes as a Function
of Time.(A)) Graphical representation of the process of sample preparation. Native and unbound
protein that may be formed during the course of reaction was removed using an amylose resin column
which would bind native protein and 100kD centricon to remove any DM-MBP that remains unbound to
GroEL. (B) SpFRET distributions obtained as mentioned earlier. After initiating GroEL/GroES/ATP
mediated refolding of DM-MBP(30−312), the reaction was terminated using EDTA and apyrase at (C)
90sec and (D) 300sec.
Thus, during successive chaperonin cycles, not-yet folded protein may revert to the
locally expanded conformational ensemble of the initial bound state. To test whether
unfolding upon re-binding is sufficiently rapid to precede encapsulation by GroES, a
collapsed DM-MBP(52 − 298) folding intermediate was mixed with the asymmetric
GroEL/GroES/ADP complex, the natural substrate acceptor state in the reaction cy-
cle (Rye et al., 1999). A conformational expansion was observed by FRET to occur at
a rate comparable to unfolding upon binding to unliganded GroEL (Fig.4.18). Thus,
transient unfolding may occur upon substrate re-binding during successive chaperonin
cycles, possibly re-setting kinetically trapped intermediates to a higher position in the
energy landscape. However, in the case of DM-MBP, this process does not contribute to
the 10-fold rate acceleration of folding, because fully accelerated folding occurs with a
single round of encapsulation in SR-EL/GroES, independent of iterative binding cycles.
This would suggest that for DM-MBP iterative annealing does not lead to any further
conformational change of GroEL bound DM-MBP.
In an in vivo scenario, GroEL is a down stream chaperone and in the view of the
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Figure 4.18: Kinetics of the Conformational Rearrangement of DM-MBP (52 − 298)
Upon binding ”GroEL-Bullet” To obtain the kinetics of the conformational rearrangement of DM-
MBP(52 − 298) upon binding to GroEL in a more physiological situation, 1µM GroEL/GroES/ADP
bullets were reconstituted and was mixed with 100nM of DM-MBP(52 − 298) in the presence (green)
or absence (red) of ATP or with buffer alone(blue).
”Pathway Model” of chaperone function in the cell, the substrate most likely is handed
down from some of the up-stream chaperones such as DnaK/J system. Therefore, to
investigate whether under such circumstances the substrate undergoes any expansion
upon binding to GroEL, EFRET of the DM-MBP(52-298) was measured when bound to
DnaK/J system in the presence of ATP, then GroEL and GrpE were added to facilitate
transfer to GroEL and the EFRET measured and compared to that of the spontaneous
intermediate, bound to DnaK/J, bound to GroEL, and from DnaK/J transferred to
GroEL (Fig.4.19). It can be seen that upon transfer from the Hsp-70 system, the sub-
strate protein undergoes expansion upon binding GroEL, indicating that this expansion
may be important for some substrate proteins to be pulled out from kinetically trapped
conformation.
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Figure 4.19: FRET efficiencies of DM-MBP(52 − 298) when bound to GroEL or DnaK/J
system or a folding intermediate in the spontaneous folding pathway. To obtain the steady
state EFRET of DM-MBP(52− 298), denatured protein was diluted into Buffer A alone or with GroEL
(3µM) or DnaK/J (1.25µM and 0.6µM respectively). To facilitate transfer from DnaK/J to GroEL
1.25µM of GrpE was added along with GroEL.
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4.10 Binding and Segmental Release of Substrate by
GroEL
Steady-state anisotropy measurements3 with the Atto532 dye attached to single cysteines
positioned throughout the DM-MBP sequence were performed to obtain insight into how
GroEL binding restricts the mobility of the protein. Since the lifetime of Atto532 is on
the order of 4 ns or less, the steady-state anisotropy of labelled DM-MBP is affected
most by the restriction of segmental mobility of the protein resulting from binding to
GroEL, which has a rotational correlation time orders of magnitude larger than the life-
time of the dye. Segmental mobility differed substantially for different regions of the
GroEL-bound protein (Fig.4.20). A flexible N-terminal segment (first 40 residues) is
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Figure 4.20: Segmental Mobility of Different Regions of the Labelled DM-MBP When
Bound to GroEL. The steady-state anisotropy of the single cysteine mutants of DM-MBP labelled
with (Atto-532) were measured when the protein was bound to GroEL (filled black Squares with black
line) and with addition of ATP (filled red circles with red line) to the GroEL bound complex.
followed by a highly immobile region (next 200 residues). This segment also contains
the most hydrophobic regions of DM-MBP, possibly constituting the hydrophobic core
of the folded protein. In contrast, the following 30 residues are more mobile, followed by
a mobility-restricted C-terminal segment.
Binding of ATP to GroEL is known to decrease the affinity of the chaperonin towards
unfolded proteins. In order to verify the same for DM-MBP, equilibrium dissociation
constants for the binding of DM-MBP to GroEL, GroEL/ATP and SR-EL were obtained
(Fig.4.21). Fraction of DM-MBP bound to chaperonin was obtained by the amplitude of
3anisotropy experiments were done by Kausik Chakraborty
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Figure 4.21: Determination of KD of the chaperonin for the substrate protein. 100nM DM-
MBP(52C) was taken in a syringe and then mixed with different concentrations of GroEL (red), SR-EL
(blue) and GroEL with ATP (black). The bound proportion of the protein was estimated by fitting
the curve and taking the amplitude change as a function of concentration of the substrate-chaperonin
complex formed. The proportion of bound protein was estimated from the amplitude change (inset) of
the labelled protein when mixed with different concentration of chaperonin.
fluorescence change of DM-MBP(52C) labelled with Atto-532 upon binding to GroEL.
Equilibrium dissociation constant was obtained by quantifying the fluorescence ampli-
tude change as a function of chaperonin concentration, and fitting the resultant graph
to the equation:
B =
(c+ x+KD)− 2
√
(c+ x+KD)2 − 4× x× c
2
where B is the concentration of the bound labelled DM-MBP to the chaperonin, c is
the total concentration of chaperonin, x is the total concentration of DM-MBP labelled
with Atto-532 and KD is the equilibrium dissociation constant. The equilibrium dissoci-
ation constant as expected was lower for GroEL (60 nM) than for GroEL/ATP (130nM)
and SR-EL (170nM). This shows that the binding affinity of GroEL for unfolded protein
is significantly decreased in presence of ATP. In line with this thought, we investigated
whether ATP dependent conformational changes in GroEL modulate the structure of
the bound substrate in a global manner. We have seen that ATP induced structural
changes in the chaperonin manifests itself in structral rearrangements in the substrate
protein in a position specific manner.
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Therefore, we wanted to probe whether the release of the substrate protein from the
apical domain is concerted or it follows a segmental release in a position specific manner.
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Figure 4.22: Segmental Release of the Protein as Studied by Steady-State Anisotropy
using a Stopped-Flow Apparatus. 100nM DM-MBP(345)/SR-EL complex (B) was prepared by
diluting 5µM of unfolded protein in buffer containing 1µM of SR-EL. This sample was loaded in one
syringe of the stopped flow apparatus and mixed with an equal volume of buffer (blue), ATP(red), or
ATP and GroES (green) to obtain the conformational change in DM-MBP upon binding of nucleotide
to SR-EL.
Interestingly, addition of ATP had only little effect on the mobility of the hydrophobic
regions, but strongly increased the mobility of the more flexible, loosely bound segments
5.1.
Stop-flow mixing experiments with DM-MBP labelled at position 345 in the C-domain
showed that this segmental release occurred rapidly within 100 milliseconds upon ATP
addition and was not accelerated by the simultaneous presence of GroES (Fig.4.22). In
contrast, the tightly bound segment in the N-domain was only released upon addition
of GroES (Fig.4.23). Significantly, this occurred at a time scale slower than release of
the C-domain segment. Thus, hydrophobic collapse of the protein upon encapsulation
by GroES follows a step-wise mechanism in which less hydrophobic regions are released
from GroEL prior to more hydrophobic ones, reversing the order of burial of hydropho-
bic segments during spontaneous folding. Indeed, a rapid, indiscriminate collapse was
observed for DM-MBP upon dilution from denaturant, as indicated by similar rates of
compaction for the various FRET pairs.
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Figure 4.23: Segmental Release of the Protein as Studied by Steady-State Anisotropy
using a Stopped-Flow Apparatus. 100nM DM-MBP(52)/SR-EL complex was prepared by diluting
5µM of unfolded protein in buffer containing 1µM of SR-EL. This sample was loaded in one syringe of
the stopped flow apparatus and mixed with an equal volume of buffer(blue), ATP(red), or ATP and
GroES(green) to obtain the conformational change in DM-MBP upon binding of nucleotide to SR-EL.
4.11 GroEL-GroES assisted and Spontaneous Fold-
ing Pathways
FRET efficiencies were calculated for 3 pairs of positions to estimate the compaction and
conformation of the protein in general while it is inside the GroEL cavity. One of the
positions (298), was kept fixed as it could be protected from labelling upon addition of
maltose, and the other positions (52, 345 and 175) were chosen so that the spontaneous
refolding rates obtained are not affected upon mutagenesis to cysteine or upon labelling
of the cysteines. Double labelling was performed as described in materials and methods
and double labelling was confirmed by life-time analysis of the labelled protein which
exhibited less than 5% component from single labelled species.
The FRET efficiencies for the different FRET pairs of the folding intermediate were
obtained by extrapolating the refolding curve to the initial time point. It is observed that
the protein is highly compact with some positions being as compact as the native state
within 10 seconds of initiating the refolding reaction. Similar compaction is also seen for
spontaneous folding indicating that DM-MBP undergoes a fast hydrophobic collapse re-
sulting in a compact state both in spontaneous and GroEL/SR-EL assisted folding. The
efficiencies for the intermediate obtained with DM-MBP(52 − 298) (Fig.4.24A) FRET
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pair were similar for spontaneous refolding and GroEL/ES/ATP mediated folding, indi-
cating that confinement of the protein in the GroEL cavity does not change the structure
of the intermediate in this case significantly. For DM-MBP(345 − 298) we see a differ-
ence (Fig.4.24B) in the efficiencies obtained for the SR-EL/ES/ATP as compared to the
spontaneous refolding. For this distance, the refolding intermediate formed in SR-EL is
slightly more expanded than the refolding intermediate formed spontaneously but the
native states have similar distances. SR-EL/ES/ATP mediated refolding for these FRET
pairs are identical to that of GroEL/ES/ATP mediated refolding. The efficiency of the
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Figure 4.24: Ensemble FRET Efficiency of the Intermediate and the Native State Formed
in Case of Spontaneous Refolding, GroEL and SR-EL Mediated Refolding. Refolding of
GuHCl-denatured DM-MBP in buffer B (12.5µM) at 25oC upon 50-fold dilution into reactions containing
either buffer A alone (spontaneous, black), buffer A with 1.0µM SR-EL (grey) or 0.5µM GroEL (light
grey) and 1.0µM GroES, 2 mM ATP, for DM-MBP(52 − 298)(A), DM-MBP(298 − 345)(B) and DM-
MBP(175− 298)(C).
intermediate of DM-MBP(175−298) (Fig.4.24C) pair shows a more expanded conforma-
tion for the intermediate in the chaperonin cavity compared to the spontaneous refolding
intermediate. Though this might not provide a realistic estimate of the distance or the
dimension of the intermediate due to a change in Ro, it indicates that the conforma-
tion of the intermediate is different inside the cavity. Maltose binding was monitored to
confirm that the protein reached the native state in case of both GroEL mediated and
spontaneous folding as shown previously.
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The FRET efficiency for the intermediate as well as the refolded protein shows a dif-
ference in FRET efficiency in SR-EL as compared to spontaneous reaction or GroEL
refolded protein. This could be attributed to the fact that the refolded protein is
trapped inside the SR-EL cavity with an altered conformation, and the efficiency reaches
the native state value when CDTA is added to release the protein from the SR-EL
cavity(Fig.4.24C). This is also confirmed by SpFRET.
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Figure 4.25: Sp-FRET Efficiency Distribution of the Intermediate and the Native State
Formed in Case of Spontaneous Refolding and SR-EL Mediated Refolding. Sp-FRET dis-
tribution of the refolding intermediate of DM-MBP(175 − 298) formed during the first 200 seconds
of spontaneous (A) and SR-EL/GroES/ATP mediated (B) refolding reaction were obtained. The Sp-
FRET distributions of the spontaneously refolded protein (C) and SR-EL/GroES/ATP refolded protein
trapped in the SR-EL cavity (D) were also obtained.
The EFRET values from single-molecule measurements for the folding intermediates
at 200 seconds after initiating folding, when 10% (spontaneous) and 40% (assisted) of
total DM-MBP have reached native state (Fig.4.25 A and B), were overall similar for
spontaneous and chaperonin mediated refolding, but the SR-EL-enclosed protein was
slightly more expanded than the free form. Similarly, the end-state of folding reached
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inside the chaperonin cavity was somewhat more expanded than the free native state
(Fig.4.25 C and D).
Though the conformation of the folded protein inside the SR-EL cavity is altered, it
is observed that upon addition of maltose there is a change in efficiency and it reaches
the same value obtained for maltose-bound native protein, indicating that the folded
form is able to bind maltose and is in fact the native state with local conformational
differences with the native protein in solution. This raises the possibility that the GroEL
cavity has the ability to effect local conformational changes upon the intermediate as
well as the native state.
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Figure 4.26: Rate of Spontaneous and GroEL Assisted Refolding of DM-MBP and DM-
MBP(30−298). Effect of mutations D30C and P298C on the rate of refolding (A) as seen in spontaneous
refolding of DM-MBP(30 − 298) (green) as compared to DM-MBP (dark-blue) and SR-EL mediated
refolding of DM-MBP(30− 298) (royal-blue) and DM-MBP (red).(B) Isothermal chemical denaturation
curves to compare the thermodynamic stabiltity of DM-MBP and DM-MBP(30−298). 250nM of either
protein wsa incubated in buffer A containing different concentrations of GdnHCl for 4 hours at 25oC
before obtaining fluorescence readings. Fluorescence was measured at 350nm (slit width 5nm) with
excitation at 295nm (slit width 2nm) (C). Unfolding of DM-MBP and DM-MBP(30 − 298) at 1.5M
GdnHCl as observed by Trp fluorescence.
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If the folding pathway is altered in the GroEL cavity compared to the pathway dur-
ing spontaneous refolding the rates would be hypothesized to behave differentially to
rate perturbing mutations or external conditions. The mutations D30C and P298C on
DM-MBP was found to accelerate the spontaneous refolding rate by approx. 2.5 fold
(Fig.4.26A) without a change in the stability of the protein (Fig.4.26 B) or the unfolding
rate (Fig.4.26C). There is a slight shift in Cm though the 4G values obtained from the
fits ( 4.7kcal /mole for DM-MBP and 4.1 kcal/mole for DM-MBP(30− 298)), indicating
that rate enhancement of refolding of DM-MBP(30− 298) compared to DM-MBP does
not result from increased stability of the protein. DM-MBP and DM-MBP(30 − 298)
exhibit identical unfolding rates, which indicates that the faster rate of folding of DM-
MBP(30 − 298) is not resultant from a slower unfolding rate of the protein. Identical
rates of unfolding of DM-MBP(30− 298) and DM-MBP are also obtained for other con-
centrations of GdnHCl.
This indicates that D30 and P298 play a role in decelerating the spontaneous refolding
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Figure 4.27: Effect of D2O on the Refolding Rate of Spontaneous Refolding and SR-EL
Mediated Refolding. Spontaneous refolding of DM-MBP in the absence (dark-blue) and presence
(green) of D2O and SR-EL mediated refolding of DM-MBP in the absence (red) and presence (royal-
blue) of D2O.
process. In contrast to spontaneous refolding, the SR-EL mediated refolding rate of the
protein is not affected by this mutation. This suggests these residues play a rate-retarding
role during the spontaneous folding process whereas it does not play a discernible role
during the folding of the protein in the GroEL cavity. This can be explained only if the
pathways are different with respect to the local structure formed around these residues
in the folding intermediate or in the rate limiting transition state.
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It has been shown in previous studies that D2O can increase the hydrophobic ef-
fect and hence perturb folding rates. In the case of DM-MBP, D2O, accelerated the
spontaneous refolding rate by approx. 3 fold when compared to H2O (Fig.4.27). This
may be due to an increase in the rate of hydrophobic collapse in D2O. In contrast to
spontaneous refolding, the GroEL mediated refolding rate is not changed in the pres-
ence of D2O. The fact that the spontaneous folding pathway can be affected by D2O
whereas the GroEL mediated folding pathway is insensitive to the same indicates that
the pathways are different.
This result together with the fact that the conformation of the intermediate, as
monitored by DM-MBP(175 − 298), is different in GroEL mediated folding indicates
that GroEL may affect these changes by mediating a controlled collapse of the locally
expanded substrate protein and confining folding intermediates in a hydrophilic cage. It
seems likely that the changes in the structural features of the intermediate prevails in
the refolded protein as long as the protein is encapsulated in the GroEL cage indicating
that the cavity surface has the potential to remodel the structure of a refolding protein
through confinement and/or surface interactions.
Chapter 5
Discussion
5.1 GroE and Protein Folding
Protein folding of newly synthesized proteins in the cell is generally dependent on the
assistance of molecular chaperones. The chaperone systems of E.coli, in particular the
GroE system, have been the subject of intensive study. Previous works have helped to
identify the natural substrate spectrum of the GroEL-GroES system and provide quan-
titative information on substrate interaction as well as revealed direct insight into the
degree of chaperone dependence of the identified substrate proteins (Houry et al., 1999;
Kerner et al., 2005).
Mechanistically, the folding cycle has also been attempted to be elucidated and it
has been shown that folding follows upon enclosure of non-native protein in the GroEL-
GroES complex, which is essential for folding to proceed unimpaired by aggregation.
Additionally, folding inside the cage can be significantly faster than folding in free solu-
tion, independently of ATP-driven cycles of GroES binding and release (Brinker et al.,
2001).
The GroEL/GroES nano-cage allows a single protein molecule to fold in isolation.
This reaction has been compared to spontaneous folding at infinite dilution. However,
recent experimental and theoretical studies indicated that it is not a passive cage of in-
finite dilution but actively modulates the folding by exerting confinement on the folding
protein inside the limited volume of the cage; through its mildly hydrophobic, interac-
tive C-terminal tails at the bottom of the cage; and by the clusters of negatively charged
amino acid residues exposed on the cavity wall (Tang et al., 2006).
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5.2. THE CHAPERONIN DM-MBP BOUND STATE AT SINGLE-MOLECULE
RESOLUTION.
5.2 The Chaperonin DM-MBP Bound State at Single-
Molecule Resolution.
The expanded structure observed in the GroEL bound state for the protein double la-
belled at position, 52C and 298C clearly shows that, even under solution conditions that
strongly favor folding, the protein can be significantly opened up when bound to the
apical domains of GroEL. Though it has been previously reported that proteins might
show an expansion when bound to GroEL (Lin and Rye, 2004), this study clearly showed
that the opening up on the GroEL surface may have been underestimated when probed
by ensemble measurements.
The Chaperonin-Substrate complex has been speculated to be a heterogenous dis-
tribution as the NMR based study was not able to resolve a number of peaks (Horst
et al., 2005) and hence was not able to give exhaustive structural insight into the bound
state conformation. Recent studies using Cryo-Electron Microscopy and Malate Dehy-
drogenase as the model substrates have attempted to investigate the nature of the bound
substrate when bound to GroEL (Elad et al., 2007), but lacks the information of subse-
quent changes, if any, in the protein conformation upon nucleotide and GroES binding.
Moreover, as the sample itself is frozen, it limits the information regarding the dynamics
of the bound state.
For the first time, in this study, we have been able to explore the GroEL bound
substrate conformation at single molecule resolution, which gives us an insight into the
heterogeneity which has been otherwise compromised in previous studies. The substrate
protein bound to GroEL shows a bimodal distribution of conformations. One of the
populations is as expanded if not more than the unfolded protein in denaturant and the
other population is compact similar to native like distributions. At the same time, this
is not a global phenomena and different regions of the protein experience varying degrees
of unfolding upon binding to GroEL.
5.3 Bimodal Distribution and Allosteric Regulation
It is also seen that the expanded conformation seen on the GroEL surface is not dis-
cernible during the initial phase of spontaneous refolding of the protein, indicating that
the surface of GroEL with its multivalent binding capability has the unique ability to
present an unfolding environment even under conditions that strongly favor folding.
The most expanded state of the unfolded protein results from binding to the nucleotide-
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free, high affinity state of GroEL. Thus, the bimodal distribution in the conformation of
bound protein observed in the absence of nucleotide suggests that normally an equilib-
rium exists between high and low-affinity GroEL states, the latter of which is stabilized,
rather than induced, by nucleotide binding. This is consistent with the theory of nested
cooperativity (Yifrach and Horovitz, 1995). According to this theory, the subunits within
a ring are in equilibrium between a T state, which has a high affinity for the unfolded
protein substrate but low affinity for ATP, and an R state, which has the converse prop-
erties. Allosteric regulation is mediated by the protein and the nucleotide in opposite
directions of equilibrium between the two states of GroEL (Poso et al., 2004).
5.4 GroEL Binding Induced Local Unfolding
The energy landscape of the kinetically populated folding intermediate of DM-MBP is
altered by GroEL. Upon dilution of the unfolded protein into refolding buffer, distinct
native like distributions of FRET efficiencies are obtained for different FRET pairs in
the folding intermediate. The observation that there are unimodal distributions with
different FRET pairs indicates that there is a local energy minimum on the folding path-
way of DM-MBP. This is changed upon the binding of the intermediate to GroEL. The
presence of bimodal distribution indicates that there are multiple minima when the pro-
tein is bound to GroEL.
Increase in the width of the distributions upon binding of GroEL indicates that the
minima are shallow. The increase in the heterogeneity of the distribution upon GroEL
binding also indicates that the bound state of DM-MBP has higher conformational en-
tropy than the collapsed state of the protein formed at the start of spontaneous refolding.
The restructuring of the energy landscape by GroEL can, in principle, cause the protein
to be removed from a kinetically trapped energy minimum, resulting in an accelerated
refolding process.
Expansion of protein by nucleotide-free GroEL may be of significant importance for
proteins that might need only the unfolding action of the GroEL apical domain to facil-
itate their folding.
5.5 Bound State and the Rate of Folding
In the case of DM-MBP, we see that in SR-EL the expanded conformation is either absent
or present in a lower fraction as compared to GroEL, even though SR-EL, is observed to
accelerate the refolding of DM-MBP to the same extent as GroEL. This indicates that
92
5.6. NUCLEOTIDE INDUCED TRANSIENT UNFOLDING AND SUBSEQUENT
COMPACTION UPON GROES BINDING
the percentage of expanded conformation does not correlate with the rate acceleration
of refolding of DM-MBP. Although the presence of the more opened-up state on GroEL
may provide an opportunity for some of the substrate proteins to be stretched out of
their kinetically trapped conformations, this observation negates the possibility of the
presence of this stretched out bound state being a necessary step for the rate enhance-
ment of folding in case of DM-MBP.
A crucial difference between GroEL and SR-EL in their functional capabilities in
vitro might be in their differential ability to unfold proteins that need unfolding as a
necessary event in order to initiate their refolding process. It will be of importance to
see whether proteins that are unable to refold in the presence of SR-EL in vitro and does
so in the presence of GroEL gain from the ability of GroEL to unfold the protein.
5.6 Nucleotide Induced Transient Unfolding and Sub-
sequent Compaction Upon GroES Binding
It has earlier been hypothesized that the binding of ATP to GroEL causes forced un-
folding of the protein (Shtilerman et al., 1999). In this work, it is shown that DM-MBP
bound to GroEL/EL-SR undergoes transient expansion upon binding of ATP. This hap-
pens on the time-scale of ATP binding to GroEL/EL-SR indicating that ATP binding
and not hydrolysis is essential for the unfolding of the protein.
This unfolding is followed by subsequent compaction, as monitored by SpFRET to
yield more compact conformational states. Subsequent GroES binding to the complex re-
sults in compaction of the protein without any further expansion indicating that GroES
binding does not cause any forced unfolding event. Under conditions where the nu-
cleotide induced expansion of DM-MBP is slow (in the presence of ADP:AlFx) or absent
(in the presence of 750mM (NH4)2SO4; which offers a highly hydrophobic environment)
the rate of refolding is not altered.
Under such conditions, SR-EL is nonetheless able to accelerate the refolding of DM-
MBP to the same extent as that of ATP induced transient unfolding suggesting that
ATP induced expansion of DM-MBP is not an essential event for the rate acceleration of
refolding of DM-MBP. It may be essential for some other substrate proteins. It was also
observed by SpFRET experiments that within the first 200 seconds of the spontaneous
refolding or EL-SR/GroES/ATP mediated refolding reaction, DM-MBP reaches near
native compaction with a unimodal distribution. The absence of expanded states under
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these conditions indicates the absence of expanded intermediates in the spontaneous or
chaperonin assisted folding pathway of DM-MBP.
5.7 Step-Wise Release of the Substrate Protein from
GroEL
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Figure 5.1: Segmental Mobility of Different Regions of the Labelled DM-MBP When
Bound to GroEL Correlated With Hydrophobicity. The steady-state anisotropy of the single
cysteine mutants of DM-MBP labelled with (Atto-532) were measured when the protein was bound to
GroEL (filled black Squares with black line) and with addition of ATP (filled red circles with red line)
to the GroEL bound complex. The hydropathy index of DM-MBP, calculated from the sequence using
Abraham and Leo scale of hydrophobicity with a sequence window of 19 residues is also shown (dashed
line).
The release of the unfolded protein from the GroEL apical domain upon addition of
ATP and GroES appears to occur in a stepwise manner. With regions of lower hydropho-
bicity being released in the first phase, when GroEL binds ATP, followed by the release
of other regions upon binding of GroES to the GroEL/ATP complex. The binding of
GroEL apical domain to substrate protein is believed to be mainly driven by hydropho-
bic interactions and it is also well known that nucleotide binding to GroEL induces
conformation change in the apical domain in the chaperonin resulting in a decreased
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5.8. RATE ACCELERATION BY GROEL VIA A DIFFERENT FOLDING
PATHWAY
hydrophobic surface area (Kim et al., 2005). Therefore, the release as measure by the
anisotropy correlates well with the hydropathy plot of DM-MBP calculated from the
sequence using Abraham and Leo scale of hydrophobicity with a window of 19 residues
(Fig.5.1).
The observation that the release of the substrate protein happens in a stepwise man-
ner is easily explainable with the reduction of hydrophobic area on GroEL apical domain
upon ATP binding and release of all but the highly hydrophobic regions of the protein
which are released only after further conformational changes/or steric competition upon
GroES binding. The biphasic release has the potential to alter the folding pathway of
DM-MBP inside the GroEL cavity. Since it is well known that the initial collapse of most
of the proteins are driven by hydrophobicity (Dill and Chan, 1997), sequestration of the
most hydrophobic regions of the protein by GroEL and releasing the weaker hydrophobic
segments before the segments with higher hydrophobicity may cause the protein to col-
lapse differently from the spontaneous refolding event, leading to a different intermediate
formation in the GroEL cavity.
5.8 Rate Acceleration by GroEL via a Different Fold-
ing Pathway
GroEL/GroES/ATP mediated protein folding may be faster inside the cavity if GroEL
specifically interacts with native like elements in the transition state of refolding and,
hence, stabilizes the GroEL-ES-DM-MBP complex* (where DM-MBP* is the transition
state of refolding of DM-MBP). In this mechanism, the folding pathway is essentially
the same without any change in structural features of the intermediate or transition
state induced by GroEL. This would result in a similar behavior of the spontaneous
and GroEL/ES/ATP assisted folding pathways to external perturbations like mutation
or solvent conditions which is ruled out by the present study. Kinetic data of folding
obtained from ensemble FRET measurements suggest that the conformation of the re-
folding intermediate is altered by the GroEL cavity, which leads to a folding pathway
that is different from the spontaneous refolding pathway.
The difference in conformation of the GroEL mediated folding intermediate from the
folding intermediate formed during spontaneous folding is also retained as a difference in
conformation between the refolded protein trapped in the SR-EL cavity and the spon-
taneously or GroEL/GroES/ATP refolded protein. This indicates that GroEL is able to
change the structural properties of the intermediate as well as the refolded state which
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Figure 5.2: Schematic Representation of How GroEL-GroES May be Helping to Increase
the Folding Rate. GroEL/ES restructures the intermediates and re-routes them though a different
pathway. The free energy barriers for kinetically populated intermediates are thus decreased resulting
in global smoothening of the free energy landscape.
might lead to a different folding pathway which contains fewer kinetic traps or with a
less rugged energy landscape (Fig.5.2).
This is also supported by the fact that refolding in GroEL is less sensitive to one of
the mutations, D30C, P298C, or D2O containing buffer that accelerate the spontaneous
folding rate indicating a difference in folding pathway. This is the first report of an alter-
nate folding pathway in the GroEL cavity which should facilitate future experiments to
investigate this change as a function of confinement and surface properties of the GroEL
cavity.
5.9 The GroEL-Substrate Complex Returns to the
Initial Bound State During GroEL Cycling.
It has been previously hypothesized that iterative annealing of the unfolded protein is
essential for accelerated protein folding in the GroEL cavity (Todd et al., 1996). Here we
show that iterative annealing or cycling does not affect the starting conformational prop-
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5.9. THE GROEL-SUBSTRATE COMPLEX RETURNS TO THE INITIAL BOUND
STATE DURING GROEL CYCLING.
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Figure 5.3: ATPase Rate and Cycling does not Affect the Rate of Refolding of DM-MBP.
Representation of the different rates involved in the functional GroEL cycle. The rate of cycling does
not affect the rate of refolding as seen by mathematical simulation (B) when the ATPase rate is changed
from 5 sec to 40 sec in the super-imposable red, blue and green curve.
erties of the GroEL bound substrate protein. Upon iterative re-binding of the substrate
protein to GroEL apical domain, the unfolded protein returns to similar conformational
distribution irrespective of the number of cycling events.
Since the protein returns to the original expanded state at the end of each cycle,
it was necessary to verify by numerical simulations whether cycling could affect the
actual refolding rate of a GroEL assisted refolding reaction. To obtain estimates of
refolding rates under conditions involving GroEL/ES cycling, numerical simulations1
were performed with the kinetic scheme as shown in (Fig5.3A). The rate for the binding
and encapsulation of DM-MBP under the conditions used for the reactions (1µM of
GroEL, 2µM of GroES, 2mM ATP, and 250nM of denatured DM-MBP) is limited by
the binding of GroEL to the unfolded protein with a rate of approx. 4×106M−1s−1(k1),
which is followed by fast binding of GroES to result in substrate encapsulation. The
intrinsic rate of refolding of DM-MBP in GroEL was fixed at 5 × 10−3s−1 (k2) and the
ATPase induced cycling rate was varied from 0.2s−1 to 0.025s−1(k3) to obtain the effect
1This work was performed by Kausik Chakraborty.
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of rate of cycling on the final refolding rate (Fig 5.3B). It was observed that the refolding
rate of the DM-MBP under these conditions was still 5× 10−3s−1and is not affected by
the fact, that at the end of a cycle, the not yet native protein rebinds to GroEL to
form an expanded conformation. It was also observed that the refolding rate is not
affected by the cycling rate of the GroEL-GroES system, indicating that the ATPase
rate might not play a significant role in determining the rate of a refolding reaction,
which is corroborative with the data that SR-EL with one cycle of ATP hydrolysis is
able to accelerate the refolding to a similar extent as GroEL.
5.10 GroEL Dependence of a Substrate Protein
There have been many studies aiming to find any structural correlation in the native
state to the regions interating with GroEL within a protein e.g. (Stan et al., 2006) where
it has been shown that GroEL interacts with the hydrophobic stretches of a protein which
are buried and not exposed in the native state. This is also consistent with the fact that
GroEL is shown to not interact with a protein in its native state. There are also studies
that have aimed at identifying GroEL substrates by sequence alignments to the mobile
loop region of GroES (Chaudhuri and Gupta, 2005) based on the rationale that natural
substrate proteins should contain binding motifs similar in sequence to the mobile loop
peptide of GroES that displaces the binding motif during the chaperonin cycle. These
parameters, if substantiated, can be used to extrapolate it to an unknown set to predict
the GroEL dependence of a particular protein. Certain folds or structural motifs have
also been shown to be enriched as compared to the natural protein occurrence in the
proteome, for instance TIM barrels (Kerner et al., 2005).
We know that Maltose Binding Protein is not a natural substrate of GroEL as it
is a preiplasmic protein and it translocated by the Sec pathway (Collier et al., 1988).
Nevertheless the cytosolic variant of DM-MBP is a GroEL dependent Class III substrate
(Tang et al., 2006). The obvious difference between the two variants of MBP are the
folding rate and GroEL dependent rate acceleration, therefore it may be speculated that
GroEL dependence of a protein may also be dependent on its refolding pathway. As it
has been shown that the GroEL binding kinetics is in the order of seconds and the initial
collapse or compaction of a fast folding protein is in the the order of ms or even less,
the protein in such a case would not get a chance to interact with GroEL. In the case
of Maltose Binding Protein, two point mutations decelerate the rate of folding and the
resultant DM-MBP is hence dependent on GroEL.
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Appendix A
Appendix
A.1 Sp-FRET Measurement of DM-MBP Cys Con-
structs
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Figure A.1: Sp-FRET measurements of the complex of GroEL complexed with double-
labelled MBP-DM(52−298). After initiating GroEL/GroES/ATP mediated (above) and spontaneous
refolding (below) of DM-MBP(52−298), the reaction was terminated using EDTA and apyrase at specific
below mentioned time points.Measurements were taken after removing unbound and native protein.
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100 A.1. SP-FRET MEASUREMENT OF DM-MBP CYS CONSTRUCTS
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Distance between residues ~43Å
N-terminus
C-terminus
-0.2 0.0 0.2 0.4 0.6 0.8 1.0
0.00
0.01
0.02
0.03
0.04
0.05
0.06
 
 
N
um
be
r o
f e
ve
nt
s
FRET-efficiency
-0.2 0.0 0.2 0.4 0.6 0.8 1.0
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
 
 
N
um
be
r o
f e
ve
nt
s
FRET-efficiency
-0.2 0.0 0.2 0.4 0.6 0.8 1.0
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
 
 
N
um
be
r o
f e
ve
nt
s
FRET-efficiency
0.0 0.2 0.4 0.6 0.8 1.0
0.00
0.02
0.04
0.06
0.08
0.10
 
 
N
um
be
r o
f e
ve
nt
s
FRET-efficiency
GroEL Bound SR-EL Bound
Native Denatured
Figure A.2: Sp-FRET measurements of double-labelled MBP-DM(30−175) . FRET efficiency
distribution is shown for the protein bound to GroEL, SR-EL, spontaneously refolded protein, unfolded
in 3M GuHCl.
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Figure A.3: Sp-FRET measurements of double-labelled MBP-DM(52−312) . FRET efficiency
distribution is shown for the protein bound to GroEL, SR-EL, spontaneously refolded protein, unfolded
in 3M GuHCl.
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Figure A.4: Sp-FRET measurements of double-labelled MBP-DM(30−298) . FRET efficiency
distribution is shown for the protein bound to GroEL, SR-EL, spontaneously refolded protein, unfolded
in 3M GuHCl.
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Figure A.5: Sp-FRET measurements of double-labelled MBP-DM(298 − 345) . FRET effi-
ciency distribution is shown for the protein bound to GroEL, SR-EL, spontaneously refolded protein,
unfolded in 3M GuHCl.
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Figure A.6: Sp-FRET measurements of double-labelled MBP-DM(30−134) . FRET efficiency
distribution is shown for spontaneously refolded protein, unfolded in 3M GuHCl,the protein bound to
GroEL, with ADP and with ATP,.
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Figure A.7: Sp-FRET measurements of double-labelled MBP-DM(30−134) . FRET efficiency
distribution is shown for the protein bound to SR-EL, with ADP with ADP and GroES, with ATP, and
with ATP and GroES.
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Figure A.8: Sp-FRET measurements of double-labelled MBP-DM(30−134) . FRET efficiency
distribution is shown for the protein bound to SR-EL-2GGM, with ADP with ADP and GroES, with
ATP, and with ATP and GroES.
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Figure A.9: Sp-FRET measurements of double-labelled MBP-DM(30−134) . FRET efficiency
distribution is shown for the protein bound to SR-EL-δC, with ADP with ADP and GroES, with ATP,
and with ATP and GroES.
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Figure A.10: Sp-FRET measurements of double-labelled MBP-DM(30 − 134) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL-KKK22, with ADP with ADP and GroES,
with ATP, and with ATP and GroES.
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Figure A.11: Sp-FRET measurements of double-labelled MBP-DM(30 − 312) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL2GGM, with ADP with ADP and GroES,
with ATP, and with ATP and GroES.
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Figure A.12: Sp-FRET measurements of double-labelled MBP-DM(30 − 312) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL-δC, with ADP with ADP and GroES, with
ATP, and with ATP and GroES.
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Figure A.13: Sp-FRET measurements of double-labelled MBP-DM(30 − 312) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL-KKK2, with ADP with ADP and GroES,
with ATP, and with ATP and GroES.
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Figure A.14: Sp-FRET measurements of double-labelled MBP-DM(175 − 298) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL2GGM, with ADP with ADP and GroES,
with ATP, and with ATP and GroES.
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Figure A.15: Sp-FRET measurements of double-labelled MBP-DM(175 − 298) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL-δC, with ADP with ADP and GroES, with
ATP, and with ATP and GroES.
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Figure A.16: Sp-FRET measurements of double-labelled MBP-DM(175 − 298) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL-KKK2, with ADP with ADP and GroES,
with ATP, and with ATP and GroES.
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Figure A.17: Sp-FRET measurements of double-labelled MBP-DM(52 − 298) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL2GGM, with ADP with ADP and GroES,
with ATP, and with ATP and GroES.
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Figure A.18: Sp-FRET measurements of double-labelled MBP-DM(52 − 298) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL-δC, with ADP with ADP and GroES, with
ATP, and with ATP and GroES.
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Figure A.19: Sp-FRET measurements of double-labelled MBP-DM(52 − 298) . FRET effi-
ciency distribution is shown for the protein bound to SR-EL-KKK2, with ADP with ADP and GroES,
with ATP, and with ATP and GroES.
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A.2 Abbreviations
Units are expressed according to the international system of units (SI), including outside
units accepted for use with the SI. Amino acids are abbreviated with their one or three
letter symbols.
Protein names are abbreviated according to their SWISSPROT database entries.
ADP adenosine 5’-diphosphate
Amp ampicillin
AMP-PNP Adenosine 5′ − (β, γ-imido)triphosphate
APS ammonium peroxodisulfate
ATP adenosine 5’-triphosphate
BLAST Basic Local Alignment Search Tool
BSA bovine serum albumin
Cam chloramphenicol
CDTA trans− 1, 2-diaminocyclohexane-N,N,N ′, N ′ -tetraacetic acid
ClpB chaperone clpB
D donor
DM Double Mutant
DNA deoxyribonucleic acid
DnaJ bacterial Hsp40 chaperone
DnaK bacterial Hsp70 chaperone
DTT dithiothreitol
E.coli Escherichiacoli
EDTA ethylenediaminetetraacetic acid
FCCS Fluorescence Cross Correlation Spectroscopy
FCS Fluorescence Correlation Spectroscopy
FPLC Fast Protein Liquid Chromatography
FRET Fluorescence Resonance Energy Transfer
g acceleration of gravity, 9.81m/s2
GuHCl guanidinium hydrochloride
GroEL bacterial Hsp60 chaperonin
GroES bacterial Hsp10 co-chaperonin
GrpE bacterial nucleotide exchange factor of DnaK
hr hour
Hz Hertz
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IPTG isopropyl-β-D-1-thiogalactopyranoside
LB Luria Bertani
MBP Maltose Binding Protein
MOPS 3-(N -morpholino)propanesulfonic acid
OAc acetate
OD optical density
PAGE PolyAcrylamide Gel Electrophoresis
PBS phosphate buffered saline
PCR Polymerase Chain Reaction
PDB Protein Data Bank. http://www.rcsb.org/pdb/
PIE Pulsed Interleaved Excitation
SDS sodiumdodecylsulfate
Sp-FRET Single Pair FRET
TEMED N,N,N ′, N ′-tetramethylethylenediamine
TF trigger factor
TFA trifluoroacetic acid
Tris HCl tris(hydroxymethyl)aminomethane hydrochloride
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